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described in APPENDICES. Three experimental strategies and techniques 
developed through this project were included in this dissertation.
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ABSTRACT
A rabbit genomic clone containing the muscle phosphofructokinase 
(PFK) gene of approximately 17 kilobase pairs encoding 779 amino acids 
was isolated and sequenced. This gene contains 22 exons, ranging from 
45 to 190 base pairs, and is split by 21 introns of 73-3500 base pairs. 
Eighty six percent of this gene is occupied by introns. An additional 
incomplete intron is found in the 5’ flanking region, while an Alu-like 
sequence is identified in the 3’ flanking region. The amino acid 
sequence translated from the coding sequence of this gene reveals 29 
residues (amino acid numbers 479-507) which complete a previously 
unidentified gap [Poorman, R. A. et al., Nature, 309, 467 (1984)] and 4 
positions of discrepancy; Ser -> Arg (268), Leu -> Pro (442), lie -> 
Ser (558), and the insertion of an additional Arg at position 565. 
Twelve exons encoding the N-half of the protein are scattered over 13 
kbp and the other ten exons encoding the C-half are clustered in a 
length of 4 kbp. Most introns in this gene occupy positions between or 
at the ends of the secondary structural elements, but they are not 
located at identical positions in the two protein-coding halves of the 
gene. When these exons are identified with their encoded functional 
subdomains, the exon arrangement shows a duplication pattern between 
the two halves of the gene. These data support, at the gene level, the 
hypothesis that mammalian PFK evolved from a prokaryotic progenitor by 
gene duplication and divergence.
INTRODUCTION
Phosphofructokinase plays a key regulatory role in glycolysis
The glycolytic pathway is an essential metabolic pathway in all 
living organisms. This pathway degrades glucose to generate energy and 
also provides building blocks for other synthetic reactions. At least 
ten enzymes have been found to be involved in this metabolic pathway 
(Figure 1). Among these enzymes, hexokinase, phosphofructokinase, and 
pyruvate kinase catalyze the irreversible reactions. Thus these three 
enzymes would be expected to have regulatory and catalytic roles in 
this pathway. In general, the enzyme which catalyzes the first irre­
versible reaction and this reaction is unique to this pathway would be 
considered as the key regulatory enzyme. Although hexokinase catalyze 
the first irreversible reaction, glucose to glucose 6-phosphate, its 
product (glucose 6-phosphate) is not only a glycolytic intermediate. 
It can also be oxidized by the pentose phosphate pathway to generate 
NADPII or be converted into glycogen by gluconeogenesis. On the other 
hand, phosphofructokinase (ATP:B-D-fructofuranose 6-phosphate 1-phos­
photransferase, EC 2.7.1.11(PFK)), which catalyzes the transfer of the 
gamma-phosphate from ATP to the carbon-1 hydroxyl of D-fructose 6- 
phosphate to form ADP and D-fructose 1,6-biphosphate, is the first 
irreversible reaction unique to the glycolytic pathway. Thus, PFK is 
highly appropriate to be the key regulatory enzyme in glycolysis ( 
Passonneau & Lowry, 1962).
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Figure 1. The glycolytic pathway (taken from Stryer, 1981 )
Frucotse-bisphosphatase catalyzes the decomposition of fructose 
1,6-bisphosphate into fructose 6-phosphate by hydrolysis of the phos­
phate ester at C-l in gluconeogenesis. This is an opposite irreversible 
reaction of PFK. It seems that PFK and FBPase perform a futile cycle; 
phosphorylation of fructose 6-phosphate to fructose 1,6-diphosphate and 
hydrolysis back to fructose 6-phosphate. However, both reactions are
not simultaneously fully active in most cells because of reciprocal 
allosteric controls. Koemer et al. (Koemer et. al., 1977) proposed a 
regulatory mechanism for both enzymes. In this mechanism, PFK converts 
B-D-fructose 6-phosphate (beta-F6P) to B-D-fructose 1,6-bisphosphate 
(beta-FBP). This reaction is activated by alpha-D-fructose 1,6-bisphos­
phate (alpha-FBP; the anomer of beta-FBP), but is inhibited by alpha-D- 
fructose 6-phosphate ( alpha-F6P; the anomer of beta-F6P). In con­
trast, FBPase, which is activated by beta-F6P but is inhibited by beta- 
FBP. converts alpha-FBP to alpha-FBP. This regulatory mechanism thus 
leads to reduction in the rate of futile cycling. Similar to FBPase, 
PFK is subject to allosteric activation and inhibition by various 
metabolites. For example, ATP and citrate are the inhibitors and ADP
and AMP are the activators for mammalian PFK. When the cell needs both
energy (ATP) and building block (citrate), PFK is in the active condi­
tion. When the cells are abundant in ATP and citrate, PFK would be 
inhibited by these two effectors.
Mammalian phosphofructokinases are tissue-specific isozymes
Multiple forms of PFK from various mammalian sources have been
reported. At least four forms of PFK have been found in normal and
tumor tissues of human (Layzer and Conway, 1970) and rats (Tanaka et
al., 1971). Human PM  isozymes are under the control of three struc­
tural loci (Kahn et al., 1979). It has been shown that there are three 
isozymes in rabbit (Tsai and Kemp, 1973): type A found in skeletal
muscle and heart; type B found in erythrocytes and liver; and type C 
found along with A and B in brain, thymus, and several other tissues. 
In addition, lung, adipose tissue, and stomach have an A-B hybrid set. 
Each isozyme is composed of four identical subunits. The reported 
molecular weights of these subunits are 84,000 for A subunit, 80,000 
for B subunit, and 86,000 for C subunit (Foe and Kemp, 1984).
One-dimensional chymotryptic and staphylococcal V8 pretease fin­
gerprinting analyses show that the three isozymes have different struc­
ture (Foe and Kemp, 1986 ). All three isozymes exhibit a sigmoidal 
response to increasing F6P concentration and sensitivity to inhibition 
by increasing concentration of ATP but they are kinetically distinct 
one another. Isozyme C is more sensitive than isozyme A but less 
sensitive than the isozyme B to inhibition by ATP, and less sensitive 
than isozyme A but more sensitive than isozyme B to inhibition by 
citrate (Foe and Kemp, 1986). These isozymes have different self­
association property. When they are centrifuged on sucrose gradients, 
isozyme A and B will self-associate to oligomers higher than tetramer, 
but isozyme C will not (Foe and Kemp, 1986). Immunoprecipitation 
experiments indicate that these three isozymes have different antigenic 
determinants. Isozyme C will not precipitate with the antiserum raised 
against■isozyme A or isozyme B.
Random tetremerization of these subunits may produce various homo- 
and heterotetrameric isozymes. These hybrid isozymes are also disting­
uishable from one another by the difference in their self-association,
one dimensional peptide mapping, immunoprecipitation and regulatory 
kinetic properties (Foe and Kemp, 1986). Thus the separate properties 
of isozymes A, B, and C cannot be used to predict the properties of 
hybrid isozymes.
Hie amino acid sequence of rabbit muscle FFK
Rabbit muscle PFK (EMPFK), isozyme A, has been studied for a long 
time since this enzyme revealed attractive allosteric features for 
enzymologists (Hofmann, 1978). A nearly complete amino acid sequence 
of 749 residues has been reported (Poorman et al., 1984). However, the 
reported amino acid sequence had an undetermined gap of about 30 resid­
ues in the C-terminal region. One of the features for this undetermi­
ned gap is that the correspondant peptide is very hydrophobic (Kemp, 
unpublished data). This feature makes the purification of this peptide 
difficult. More importantly, this gap comprises part of the substrate 
ATP binding site in the C-terminal of RMPFK. Identification of resi­
dues in this gap is important for understanding the function of the C- 
terminal of RMPFK.
Hie features of Bacillus stearothermophilus PFK
Among PFKs, Bacillus stearothermophilus PFK(BsPFK) is the most 
well studied case. BsPFK is a tetramer of identical subunits each of 
molecular weight 36,000. The complete amino acid sequence of 316 resi­
dues has been determined (Kolb et al., 1980). Kinetic analysis reveals 
that BsPFK has a sigmoidal response in the presnece of substrate F6P 
and is allosterically regulated by ADP, an activator, and phosphoenol 
pyruvate (PEP), an inhibitor. As compared to RMPFK, BsPFK is about
half the size of RMPFK and is regulated by a less effector. BsPFK is
not inhibited by ATP and citrate, nor activated by AMP and fructose
bisphosphate (F6P). The crystal structure of the active conformation
0has been solved to 2.4 A resolution (Evans and Hudson, 1979) and inac-
0tive conformation has also been sloved to 7 A resolution (Evans et al., 
1986). Three ligand-binding sites (ATP, F6P, and ADP binding sites) 
have been located in this crystal structure (Figure 2). The active 
site includes substrate ATP and substrate F6P binding and the effector 
site includes activator ADP and inhibitor PEP binding. These are three 
distinct features of these binding sites: (1) the position of gamma-
phosphate of ATP is very close to the 1-hydroxyl of F6P, (2) the bin­
ding of the phosphate of F6P involves two arginines from a neighboring 
subunit in the tetramer; and (3) the activator ADP is also bound by 
residues from two subunits. The first feature reveals that there is a 
suitable position for in-line gamma-phosphate transfer from ATP to F6P. 
The second and third feature suggest that there are rearrangements of 
the subunits when the enzyme reacts with substrates or effectors and 
these rearrangements will result in the conformational change of enzyme 
(Evans et al., 1981) .
The features of the hypothetic RMPFK protein model
Strong homology has been observed between BsPFK and rabbit muscle 
PFK and between the N- and C-halves of rabbit muscle PFK (Poorman et 
al., 1984; Figure 3). The respective identities for each comparison 
are 44% (BsPFK vs N-half), 34% (BsPFK vs C-half) and 32% (N-half vs C- 
half). Based on comparative sequence analysis, X-ray crystallography 
of BsPFK, chemical modification studies, kinetic analysis and limited
7
E ffec to r
s t e
Figure 2. Schematic views fo two subunits along the x-axis in the BsPFK 
tetraroer. B-strands are indicated by arrows (A-K) and alpha-helices by 
cylinders (1-13). The subunits ATP and F6P are shown in the active 
sites and the activator ADP in the effector sites (taken from Evans & 
Hudson, 1979 ).
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Figure 3. Homology comparison of related PFKs and position of introns 
along the amino acid sequence of rabbit muscle PFK. The amino acid 
sequence of Eh coli PFK (Ec PFK-1), stearothermophilus PFK (Bs PFK)
and the N-half (RM-PFK (N) and C-half (RM-PFK (C)) of rabbit muscle PFK 
are aligned for maximum homology. Double headed arrows above the 
sequences indicate secondary structural elements found in B^ stearo­
thermophi lus PFK. Introns (solid triangles) in the N- and C- halves of 
rabbit muscle PFK are positioned between the respective amino acid 
residues. Underlined regions are corrected or newly identified amino 
acid residues in all three PFK sequences. Residues boxed with square 
boxes are binding sites for substrate ATP; diamond-shaped boxes, bind­
ing sites for ATP inhibitor or ADP activator, circle boxes are binding 
sites of F6P and FBP (modified from Hellinga and Evans, 1985 with 
permission).
proteolysis data, Poorman and his coworkers proposed a protein model 
for RMPFK (Poorman et al., 1984; Figure 4). The major assumptions in 
this model are:
(1) The evolution of proteins proceeds with conservation of three- 
dimentional structure, despite wide-ranging diversification of amino 
acid sequence. Similar to the subunit structure of BsPFK, each half of 
RMPFK would also consist of two domains (Figure 2). Each domain has a 
central B-sheets core sandwiched by alpha-helices (alpha/beta class 
protein (Levitt and Chothia, 1976)). The first domain has seven stra­
nds of B-sheet, the central five being parallel, and the outer two 
antiparallel to the others. Alpha-helices 1 to 5 and 10 to 12 surround 
the central B-sheets core. The second domain has four parallel strands. 
Alpha-helices 6 to 9 and 13 surround the central B-sheet core. The two 
B-sheets cores point towards a deep cleft which forms the active site. 
The substrate ATP is bound almost entirely by domain 1 of N-half. This 
site lies between helix 5 (residue 102-108, N-half; Figure 3) and a 
surface loop between helices 3 and 4 (residues 72-77, N-half). The F6P 
molecule is bound almost entirely by domain 2 of N-half. The most 
distinct feature for this site is the involvement of residues from the 
neighboring subunit. The 6-phosphate group is bound by His-249 and 
Arg-252 from its own subunit, and by Arg-162 and Arg-243 from the 
neighboring subunit (Figure 4 and Table 1).
(2) The N- and C-halves of RMPFK monomer are joined by a connec­
ting peptide of about 30 residues (Lys 320, N-half to Ala 5, C-half; 
Figure 3). This connecting peptide brings the N- and C-halves together 
and resits in the interaction of these two halves (Figure 4).
(3) A RMPFK tetramer is roughly correspondant a BsPFK octomer and
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Figure 4. Location of substrate and effector sites in the hypothetic 
RMPFK protein model. Residues enclosed in solid boxes are identical to 
those at corresponding positions in BsPFK; those enclosed in dotted 
boxes are different. The function of each residue is explained in 
Table 1. (taken from Poorman et al., 1984 ).
Table 1. Comparison of residues in the ligand binding sites for BsPFK and N- and C-halves of RMPFK. 
(modified from Hellinga and Evans, 1985 )
BsPFK Function RMPFK(N) RMPFK(C)
substrate F6P binding substrate F6P binding activator FBP
R-162 binds 6-P R R
R-243 binds 6-P R R
H-160 subunit interface H T
D-127 catalytic residue D S
M-169 hydrophobic contact to sugar ring M M
E-222 H-bond to 04 E E
H-249 binds 6-P H H
R-252 H-bond to P6, 02, and 05 R Q
also central to subunit interface
N-12 subunit interface D P
T-156 subunit interface T X
substrate ATP binding substrate ATP binding
S-9 contact to ribose S V
G-ll main-chain amide H-bond to gamma-P G A
Y-41 contact to ribose Y F
073 main-chain amide and carbonyl H-bond 
to ribose hydroxyls
C T
K-77 hydrophobic contact to adenine R K
D-103 possible interaction with Mg D F
G-104 main-chain amide H-bond to B-P, 
carbonyl to 01’. No room for side-chain
G E
Q-107 possible H-bond to adenine N6 T E
K-lll hydrophobic contact to adenine T Q
R-71 catalytic residue (binds gamma-P) R G
activator ADP binding activator ADP binding inhibitor ATP 1
R-21 H-bond to B-P R R
R-25 H-bond to alpha- and B-P R R
D-59 main-chain amide H-bond to B-P side-chain 
H-bond to ribose 03’ and Arg-63
M G
R-63 H-bond to Asp-59, almost the only 
contact across the y-dyad
L Q
R-154 H-bond to B-P T K
G-185 main-chain carbonyl H-bond to Mg G G
E-187 carbonyl H-bonds to Mg D D
R-211 H-bonds to alpha-P and adenine N7, 
coupled with C terminus
T K
K-213 H-bonds to alpha-P T K
K-214 main-chain amide H-bond to ribose 01’ R T
would be expected to have eight active sites and eight allosteric 
sites. However, equilibrium binding studies have shown that there are 
only four catalytic sites in RMPFK tetramer. Also, RMPFK is activated 
by FBP and inhibited by ATP but BsPFK is not. These properties lead to 
the assumption that RMPFK have mutated to generate new effector sites 
and have lost half of the active sites (Figure 4). Different from 
BsPFK, the hypothetic protein model reveals an activator FBP binding 
site and an inhibitor ATP binding site in each subunit. The activator 
FBP binding site is assumed to have mutated from substrate F6P binding 
site by replacement of the catalytically essential Asp-127 with a 
serine residue (Figures 3 and 4). Asp-127 functioned as a base cata­
lyst to increase the nucleophilicity of the 0-1 hydroxyl of F6P for 
attack on the gamma-phosphate of ATP (Table 1). The replacement of 
Asp-127 by Ser in the new activator FBP binding site would remove this 
negative change and provide more room for the binding of FBP.
(4) Arg-71 is a catalytic residue to bind gamma-P in substrate ATP 
binding site. This residue is conserved in N-half and has been mutated 
to Gly in C-half. The C-half may lose the activity of substrate ATP 
binding due to this mutation. Asp-103, and Gly-104 are also important 
in substrate ATP binding, but the corresponding residues in C-half of 
RMPFK were unknown at that time.
(5) Inhibitor ATP binding site is assumed mutating from activator 
ADP binding site although the reasons are not clear.
Gene duplication and divergence
RMPFK is a tetramer of identical subunits each of which is about 
twice the size of those from BsPFK. Both RMPFK and BsPFK are alio-
steric enzymes, but RMPFK has more complex allosteric properties. 
Allignment of the amino acid sequence of RMPFK with BsPFK shows that 
RMPFK is very similar to the BsPFK (Poorman et al., 1984; Figure 3). 
In addition, the N-half and C-half of RMPFK share an internal sequence 
homology (Figure 3). This evidence leads to the speculation that 
mammalian PFK evolved from a prokaryotic progenitor by gene duplication 
and divergence (Poorman et al., 1984).
Rationales
Obviously, the hypothetical RMPFK protein model and speculated 
pathway of PFK gene evolution provides a good basis for the studies of 
RMPFK. However, there is still no experimental evidence to prove or 
disprove this hypothesis. Studies on the structural organization of 
the rabbit muscle PFK gene would therefore reveal the following signi- 
f icance:
(1) To test the speculated pathway of gene evolution.
(2) To complete the amino acid sequence of RMPFK.
(3) To provide a molecular basis for constructing a full-length 
cDNA. This full-length cDNA can be subcloned and expressed in E.coli 
cells and the sequences corresponding to those binding sites can be 
changed by site-directed mutagenesis. Mutated PFK can be made by this 
way and used to examine the hypothetical protein model.
(4) Homozygous deficiency of the muscle PFK in man results in 
glycogen storage disease (Vora et al., 1985), which is characterized by 
exertional muscle weakness and compensated hemolysis. It has also been 
found that the level of PFK specific activity of diabetic rats was 
lower than that from control rats (Bauer & Younathan, 1984). The
causes of these PFK deficiency and abnormality are still unknown. The 
RMPFK gene may serve as a good probe to approach these clinical pro­
blems.
Based on these rationales, we isolated the gene for rabbit muscle 
PFK and determined its DNA sequence. The genomic organization and 
sequence features of this gene will be presented in this dissertation.
The following three techniques are develpoed in this work. Their ratio­
nales are presented here:
Restriction mapping strategy
A detailed restriction map is very helpful for DNA sequencing and 
gene characterization. Established procedures for restriction mapping 
involve either isolation of a large amounts of target DNA and elution 
of radioactive DNA from agarose gel (Smith & Birnstiel, 1976) or repeat 
gel electrophoresis and hybridization. One strategy uses synthetic
oligonucleotides for selective end labelling (Rackwitz et at., 1984), 
however this method is only suitable for lambda phage vector. In order 
to facilitate DNA sequencing and gene characterization, we have deve­
loped a simple and direct reading method for restriction mapping. 
Thirteen restriction enzymes were successfully used to determine a 
detailed restriction map of PFK gene.
Specific DNA probes
The design of M13 phage vectors (Vieria & Messing, 1985) allows 
the isolation of single stranded DNA. Distinguishing which carried an 
insert in the vegetative phage strand usually forms an experimental 
bottle neck. The ideal probe to select Ml3 phage clones is the free
complementary strand without vector sequence. Such fragments are norma­
lly isolated by digesting the DNA of interest with restriction endonu­
cleases followed by gel electrophoresis under denatured conditions. 
Resolution of the strands by this method is usually poor. A technique 
has been developed for making strand and length specific probes. The 
idea is partly based on concepts published by Dale (Dale et al., 1986). 
The single stranded inserts can be obtained by digestion with restric­
tion enzymes at specific sites. These specific sites are formed by two 
synthetic oligonucleotides. One oligonucleotide is complementary to 
the region of EcoRI site and the other is complementary to the region 
of Hindlll site. This single stranded DNA can be radioactively label­
led at 5’ or 3’ end or homogeneously labelled on its complementary 
strand. These strand and length specific probes have been used to 
efficiently screen our Ml3 library.
DNA sequencing strategy
Currently existing DNA sequencing strategies can be classified 
into two groups: random and nonrandom sequencing. The Bal-31 method ( 
Poncz et al., 1982; Misra, 1985 ) is the well accepted one for non-
random sequencing, while the sonication method ( Deininger,1983 ) 
represents the other strategy. The sonication approach possesses the 
following disadvantages: (1 ) redundancy in sequencing and analysis is
time consuming; (2 ) multiple inserts in one vector may result in 
interference during sequence overlapping analysis. Unfortunately, the 
traditional Bal-31 methods also have disadvantages since large amounts 
of DNA must be purified from gels (Poncz et al., 1982) and low effi­
ciency of blunt end ligation and positive transformation is a problem
(Misra, 1985). In the case of the 17 kilobase pairs PFK gene, DNA 
sequencing rapidly became the limiting step. In order to sequence this 
long gene more efficiently and more economically, we improved the 
existing Bal-31 methods. This improved sequencing strategy has been 
successfully used to sequence the PFK gene fragments and will be pre­




Agarose, ammonium persulfate, ethidium bromide, and low melting 
point agarose used for gel electrophoresis were purchased from 
Bethesda Research Laboratories. Acrylamide,N’,N’-Methylenebisacryl- 
amide,N,N,N',N’-tetramethylethylenediamine (TEMED), sucrose, and
urea used for DNA sequencing were purchased from New England Bio­
labs. Inc. Amberlite (MB-1) ion exchange resin was purchased from 
Mallinckrodt. Bacto tryptone, Bacto agar, yeast extract, nutrient 
broth used for bacterial growth were purchased from Difco. Antibio­
tics ( ampicillin, chloramphenical, tetracycline ) were purchased 
from Sigma. 5-Bromo-4-chloro-3-indolyl-B-D-galactoside (X-gal) and 
isopropyl-fi-D-thiogalactopyranoside (IPTG) used for M13 cloning were 
purchased from Bethesda Research Laboratories. Dithiothreitol, 
Hexamine Cobolt (III) chloride, Rubidium chloride used for transfor­
mation were purchased from Alfa. Dideoxynucleotides and deoxynu- 
cleotides used for DNA sequencing were purchased from Pharmacia. 
The detailed preparation and composition of reagents were described 
in APPENDIX 1.
B. Radioactive Materials
Adenosine 5’-triphosphate, tetra(triethylammonium) salt,[gamma- 
3 2P] was purchased from New England Nuclear (cat# NEG-002 Z) with 
the specific activity ~500 ci/mmol. Deoxycytidine 5’-triphosphate, 
[alpha-3 2P] was purchased from ICN Biomedical Inc. (cat# 3302H) with
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the specific activity > 600 ci/mmol. Deoxyadenosine 5’-[alpha-thio] 
triphosphate,[3 5 S] was purchased from New England Nuclear (cat# NEG- 
034H) with the specific activity "10 mci/ml.
C. Enzymes
Deoxyribonuclease I (DNase I), DNA polymerase I (E. coli), 
nuclease Bal-31, ribonuclease Ti, T4 polynucleotide kinase, terminal 
deoxyribonucleotidyl transferase (TdT) were purchased from Bethesda 
Research Laboratories. Restriction enzymes and Tj DNA ligase were 
purchased from Bethesda Research Laboratories or International 
Biotechnologies, Inc. Lysozyme and ribonuclease A were purchased 
from Bethesda Research Laboratories. Pronase and proteinase K were 
purchased from Boehringer Mannheim Biochemicals. The large fragment 
of DNA polymerase I (Klenow fragment) was purchased from Boehringer 
Mannheim Biochemicals or Pharmacia or United States Biochemical 
Corporation. The preparation of enzymes and composition of buffers 
were described in APPENDICES 2 and 3.
D. Oligonucleotide
All the oligonucleotides used as probes or primers were syn­
thesized using solid support phosphite chemistry (Matteucci & Carut- 
hers, 1981) in an automated DNA synthesizer (Applied Biosystems, 
Model 380A). The name and sequence for each oligonucleotide is 
listed in APPENDIX 4.
E. Bacterial Strain and Vector
E. coli K803 was used as the host cell for lambda Charon 4A.
JM83 was used as the host cell of pUC plasmids. HB101 was used as
the host cell of pBR plasmids. JM107 was used as the host cell of
M13mpl0/ll and M13mpl8/19. The bacterial genotype and the vector 
size were listed in APPENDIX 5.
Instrumentation and Equipment
All the important instruments and equipment used in this work 
were listed in APPENDIX 5.
. Methods
Isolation and identification of rabbit muscle PFK gene
A rabbit genomic library clonded in lambda Charon 4A phage vector
was a gift from Dr. R. C. Hardison (Maniatis et al., 1978). An appro­
ximately 200 bp long cDNA of rabbit muscle PFK was obtained from Dr. S.
D. Putney (Putney, et al., 1983). The cDNA insert was further subcloned 
into pBR322 plasmid DNA, nick-translated in the presence of (alpha-32P) 
dATP and used to probe the rabbit genomic library. Positive phage pla­
ques shown to have reproducible patterns on duplicated filters were 
isolated and further purified by replating (Chang et al., 1984). Lambda 
Charon 4A/pfk DNA was prepared through cesium chloride gradient as
described (Blattner et al., 1977). Purified phage DNA was digested with
restriction endonucleases and fractionated by electrophoresis in 0.7% 
agarose gels. DNA was transferred bidirectionally onto nitrocellulose 
filters. Blots were then hybridized to 32P-labelled cDNA probe and 
synthetic oligonucleotide probe as described by Southern (Southern, 
1975). Hybridization condition using synthetic oligonucleotide probe 
and experimental details for purification of oligonucleotide are given
in APPENDIX 7.
Preparation of plasmids and Ml3 RF DNAs
Plasmids were grown in E. coli strain HB101. Ml3 clones were 
propagated in E. coli strain JM107. Plasmid and Ml3 RF DNAs were pre­
pared using an alkaline lysis procedure (Birnboim & Doly, 1979) and
subsequent purification on cesium chloride ethidium bromide gradients
(Maniatis et al., 1982). Full experimental details are given in APPEN­
DIX 7.
Restriction endonuclease mapping
M13 RF DNAs containing the desired subcloned fragments were linea­
rized and radioactivelly labelled at 5’ end with T4 DNA kinase or 3’ end 
with T4 deoxyribonucleotidyl transferase. The labelled DNAs were par­
tially digested with individual endonucleases that recognize 6 -bp sequ­
ences (EcoRI, SacI, Kpnl, Smal, Xmal, BamHI, Xbal, Sail, HincII, PstI, 
Sphl. Hindlll, and PvuII), and the digests were analyzed by electropho­
resis on 1.2% agarose gels. Gels were dried and exposed under an X-ray 
film at room temperature overnight. This autodiogram yielded a restric­
tion map for each subclone. The position and orientation of individual 
subclones were determined by the results of hybridization. The prin­
ciple of this mapping strategy are described in RESULT. The full expe­
rimental details including 5’ and 3’ ends labelling and partial diges­
tion are -given in APPENDIX 7.
Cloning and transformation
Cohesive-ended DNA fragments were cloned into plasmid pBR325 and
M13mpl8 and 19 by forced cloning. Blunt-ended DNA fragments generated 
by PvuII digestion were cloned by ligation directly into Smal site of 
bacterial alkaline phosphatase treated M13mpl8 replicative form DNA. 
Ligated DNAs were transformed into HB101 for plasmid pBR325 and JM107 
for M13mpl8 and 19. Full expermental details for the preparation of 
competent cell and transformation are given in APPENDIX 7.
Assay for Ml3 recombinants
Individual recombinant from the libraries were grown in YT broth, 
and phage RF DNA was isolated sis described (Bimboim & Doly, 1979). The 
yield of RF DNA was adequate for insert size determination. Aliquotes 
of single stranded phage from individual cultures were screened for 
insert by direct gel electrophoresis and for insert polarity by comple­
mentary test as described (Messing, 1983). Full experimental details 
for direct gel electrophoresis and complementary test are given in 
APPENDIX 7.
Dot-blot assays
Recombinant M13 phage clones were identified using filter hybridi­
zation. One ul of aliquot from the supernatant of phage stock solution 
were spotted in a grid of nitrocellulose paper. Those clones homologous 
to a particular DNA fragment were identified by DNA.DNA hybridization. 
Full experimental details for dot-blot hybridization are given in APPEN­
DIX 7.
DNA sequencing
DNA fragments were sequenced as recombinants in M13mpl8 or 19 by
the dideoxy-chain-terminator method (Sanger et al., 1977) using single 
stranded Ml3 phage DNA as templates and (alpha-35S)dATP as radioactive 
label (BNiggin et al., 1983). The primers used in these DNA sequence 
reactions were Ml3 universal primers or oligonucleotides corresponding 
or complementary to the coding regions of rabbit muscle PFK gene. Full 
experimental details from the preparation of template DNA to sequencing 
reactions are given in APPENDIX 7.
Sequence analysis
DNA sequence data were assembled and analyzed using the Staden 
programs (Staden, 1980) on a VAX 11-750 computer.
RESULTS
RMPFK gene -- gene identification, sequence analysis, and genomic
organization.
1. Identification of rabbit muscle PFK gene.
Purified lambda Charon 4A/pfk DNA was digested with res­
triction endonucleases. The results were shown in Figure 5. 
EcoRI digest on lane 4 showed 5 bands: 23 kbp, 17 kbp, 8.9 kbp, 
6.0 kbp, 2.5 kbp. The first two bands came from vector as 
compared to the known restriction map of charon 4A vector. The 
total length of the insert in this clone is therefore estimated 
to be 17 kbp. The results also showed that the insert contained 
three EcoRI sites.
Purified phage DNA was further digested respectively with 
EcoRI, PstI or PvuII, and hybridized with synthetic N-probe and 
cDNA probe. Results were shown in Figure 6. On panel (A) lane 
7, a 0.5 kbp PvuII fragment was hybridized to the synthetic N- 
probe, while 2 positive bands of PstI digest were shown on lane 
5 of Panel (B). These positive fragments were subcloned into 
M13 and sequenced. Figure 7 shows the hybridization results of 
the cloning of C-terminal fragment. All the clones were shown 
to contain the C-terminal fragment as compared with the negative 
and positive controls. Template DNAs of both strands were then 
purified and sequenced. DNA sequence of clone A corresponded to 
nucleotides 15922-16154, DNA sequence of clone B corresponded to 
nucleotides 16254-16506. The translated amino acid sequence
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Figure 5. Restriction endonuclease digestions of lambda Charon 
4A/pfk. Phage DNA, purified from the clone selected by plaque 
hybridization, were digested with restriction endonucleases. 
The digests were subjected to electrophoresis on 0.7% agarose 
gel and stained by ethidium bromide. Hindlll digest of wild 
type lambda DNA was run on Lane 12 as the size markers. The 
numbers on the right margin indicate the size and position of 
the marker fragments in kilobase pairs. Lane 1, intact; lane 2, 
Kpnl digest; lane 3, Kpnl and EcoRI digests; lane 4, EcoRI 
digest; lane 5, BamHI digest; lane 6, Kpnl and BamHI digests; 
lane 7, Hindlll digest; lane 8, Kpnl and Hindlll digests; lane 
9, BamHI and EcoRI digests; lane 10, Hindlll and EcoRI digests; 
lane 11, BamHI and Hindlll digests.
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Figure 6. Southern transfer and hybridization to probe the C- 
and N-terminal of rabbit muscle PFK gene. (A) Probing of N- 
terminal with synthetic N-probe. Phage DNA from lambda Charon 
4A/pfk were digested with EcoRI (lane 2), PstI (lane 4), PvuII 
(lane 6). Hindlll digest of wild type lambda DNA were run on 
lane 1 as the size markers. 0.7% agarose gel were electrophore- 
sed, blotted, hybridized with the synthetic N-probe as described 
in MATERIALS and METHODS. The hybridization pattern for each 
digest was arranged side by side. The arrow indicates the 
positive band of 0.5 kbp. (B) Probing of C-terminal with cDNA 
probe. All the arrangements and conditions were described in 
(A) except hybridization using the nick-translated cDNA probe.
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Figure 7. Dot hybridization to identify M13 clones containing 
the C-terminal of rabbit muscle PFK gene. A 0.5 kbp EcoRI/PstI 
fragment selected from hybridization of lambda Charon 4A/pfk to 
cDNA probe was subcloned into M13mpl8 and 19 respectively. 
Phage particles were selected for insertion by their lac phenot­
ypic change. 10 putatively positive clones from each vector 
source were chosen, spot on nitrocellulose paper, and hybridized 
with the nick-translated 0.5 kbp fragment as described in MATER­
IALS and METHODS. Blue phage particles and pure insert DNA 
fragment were spot on the same nitrocellulose paper as the 
negative and positive controls respectively. (A) M13mpl8 was 
used as vector. (B) M13mpl9 was used as vector. The open arrows 
indicate negative control; whereas the solid arrows show the 
positive control.
perfectly matched amino acids 725-732 and 766-779 (Figure 8). 
On the other hand, the 0.5 kbp PvuII fragment hybridized to 
synthetic N-probe was subcloned into Ml3. Figure 9(B) showed 
that two selected clones had slower migration as compared with 
control. Panel (A) showed that both clones contained the in­
serts of same size corresponding to 0.5 kbp. Panel (C) showed 
that these two clones had complementary inserts. Template DNAs 
purified from these 2 clones were sequenced. The deduced amino 
acid sequence matched the first 28 amino acids of RMPFK (Figure 
8). These data showed that the 17 kbp insert contained not only 
the C-terminal but also the N-terminal of PFK gene.
2. Restriction endonucleases mapping of PFK gene.
Figure 10 is the schematic representataion of this new 
strategy. The procedures are represented systematically from 
step 1 through step 6. A and B represent restriction sites in 
polylinker. In step 1, the target DNA is subcloned into restri­
ction sites of polylinker of M13 or pUC series vector. In step 
2, RF DNA is prepared and then linearized by enzyme B which 
won’t cut the inside of target DNA. In step 3, linearized DNA 
is radioactivelly labelled at 5’ or 3’ end. In step 4, the
labelled DNA can be digested with enzyme A and then go to step 5 
or leave intact for the next step. In step 5 and 5’, the label­
led DNA is partially digested with different restriction enzym­
es. In step 6 and 6’, mixture is subjected to agarose gel,
Figure 8. The nucleotide sequence of the rabbit muscle PFK 
gene. The sequence is from the site of initiation of translat­
ion (numbered with +1) to the site of termination of translation 
(numbered with 16300). The 61 bp of 5’ flanking region are 
numbered from -1 to -61 and 583 bp of 3’ flanking region are 
indicated by numbers from 16301 to 16884. The number of base 
pairs indicated in angle brackets showing the sequences which 
have not yet been overlapped. Letter X represents uncertained 
base. The numbers in the right margin correspond to the termi­
nal nucleotide of that sequence. All exons and introns are 
indicated with a title. The encoded amino acids are numbered 
above sequence. Splice junctions are indicated by emphasized 
italic. The restriction sites are indicated by each name under 
the first base. The putative Lariat branch sites are both 
numbered and indicated with asterisk. The putative Alu concen­
sus sequence and direct repeats are also designated with arrows 
below the sequence.
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o t g t c c c t a g a g t  t t  c c a g c o g a t c t g t  t t g t c c c a a a g g c c a c t t c c a g t c c a g g c c t e c t c a t t r  2 3 1 1
c t t g g t c t R a a t g c c a g g a g c c t g c c t g g g c c t g t t c c t t g g c g t c g t g c a c t g t c t c c c a g c g g c t  2 3 7  8
g c t g a t g t c t t g g g a c a c a t g g g g c t c a t t g t a t c c t g c t g c t c a c a c a g t t c t t c a g a a t t c    2 4 3 5
E c o R I
< 8 7 8  b p  > - t a t t t c a a t c c t g a g t g c c t g c c t c c a g c a a a a g g c t g t g g g g x a c t a g t g t g g a c  3 3 6 9
c t g g g g c c c c c c t a c a g t g a g t g c a c t g a t t g g g a g t g g g g a a g c x g t g c g a g g a a c t c c g a g g a c c  34  3 6
5 6
c a c a g c c g t g a c t g t g t g a g t c c t g t g c g g c t t c c c t t a g g a a a c c t c t c c tcactgtccccgcag/  3 5 0 2
t
EXON 2  
2 8
l y  M e t  A s n  A l a  A l a  V a l  A r g  A l a  V a l  V a l  A r g  V a l  G l y  l i e  P h e  T h r  G l y
GT ATG AAT GCT GCC GTC CGG GCT GTG GTT CGA GTT GGC ATC TTC ACT CGT 3 5 5 2
0 5 2
A l a  A r g  V a l  P h e  P h e  V a l  H i s  G l u
GCC CGG GTC TTC TTC GTC CAT GAG  3 5 7 6
S o a l
INTRON 2
/ g t c f l g t t c c c t c c c t c a c t g t g t g t c c c t t c t c t g a c c t c t c t c c c c c a e c c c c t c c t g g c t g c g c  3 6 4 2
t g c t t g c t c t g t c t g g c c c o c a g t c c c c a g g g t c g t g t c c a c t g t t t g c c a g t g a c g t g g g a c c a g a  3 7 0 9
c t g g t l t c c t a c c t t c c a a a g a a ----------------------------- < 6  b p  >      t c t x t  3 7 4 3
c t g a c t t t a a a t g a a g c c c a a c a c a c t g a c a c t g g g g g a g g g t g a a t t t c t c a c a g g g c c t c t t c c a  3 8 1 0
21
g g a t c c c t c t g g t c c t a a g g n c t c a g g g c c a g t g c a g c g a g g c t g a c g g g t a g e t a t a t c c c a c a f /  3 8 7 6
BaroHI >
EXON 3  
0 5 3
G l y  T y r  G i n  G l y  L e u  V a l  A s p  G l y  G l y  A s p  H i s  l i e  A r g  G l u  A l a  T h r  T r p
GGC TAC CAG GGC CTG GTG GAT GGC GGG GAC CAC ATC CGG GAG GCC ACG TGG 3 9 2 7
0 7 8
G l u  S e r  V a l  S e r  M e t  M e t  L e u  G i n  L e u
GAG AGC GTC TCC ATG ATG CTG CAG CTC 3 9 5 4
P s t l P v u I I
INTRON 3
/ f  t a g f f t t c t g g c a g c s c c g t c c t g c t c t g c c c g c t c c a g t c c t g c c a t x t g g c t  t x a g g g a c a g g a  4 0 2 0
g a g g a g c t t x t x t t t f l c c c t t t a t c t g c g t t t a a a a a c o g c a c ------------------ --------------------------------------- 4 0 6 3
9 6
1 3 9  b p  > - — - - - - - - - - - - - - c a g e t g a c t c a g g g t c a g g g a g c t t c c c c a g K t g t c  4 2 3 8
P v u l l  *
a c t g t g c t g g g n g a a g g g a t t t g g c c a t g t c a g c a g i i R g g g c c g c c t t c t . g c c t c t t t c g t c a n a / ? /  4 3 0  4
EXON 4 
0 7 9
G l y  G l y  T h r  V a l  l i e  G l y  S e r  A l a  A r g  C y s  L y s  A s p  P h e  A r g  G l u  A r g  G l u
OJA GGC ACC GTG ATT GGA ACT GCT CGG TGC AAG GAC TTC CGG GAG CGA GAG 4 3 5 5
G l y  A r g  L e u  A r g  A l a  A l a  H i a  A s n  L e u  V a l  L y s  A r g  G l y  l i e  T h r  A s n  L e u
GGA CGT CTC CCA GCC GCC CAC AAC CTG GTG AAG CGT GGG ATC ACC AAT CTG 4 4 0 6
30
C y s  V a l  l i e  G l y  G l y  A s p  G l y  S e r  L e u  T h r  G l y  A l a  A e p  T h r  P h e  A r g  S e r
TGT GTG ATA GGC GGT GAT GGC AGC CTC ACT GGG GCT GAT ACC TT C  CGT TC T 4 4 5 71
G l u  T r p  S e r  A s p  L e u  L e u  S e r  A s p  L e u  C l n  L y e  A l a  G
GAG TGG AGC GAC CTG TTG ACT GAC CTC CAG AAA GCG C  4 4 9 4
INTRON 4
/ j r t f a # a c a t g £ t t t g g a c a g g a t t a t g c g t g t g c g t g t g c a a s g g c a g g t t g t g c g c a a t t c g c a a  4 56G
t g c c a a t c t c t c t g c t g a a t a c a g c a c t t c t c t c t t t t t c a t g c t g g a - - - <  2 2 5  b p  > - - t a t t  4 8 3 7
t t g a a t t a g t a a a t t a a a g a a a g c t a t g a c a t g a t a c a a t t c a x t g t a c c c g g a t c t c t a a t c a c c t  4 9 0 4
P s
g c a g g x t t c g g g g a g c a g t g t g t g c c g t c t c a c t g a t c a a t g c t g g a g a a g g c g g g g a g a a t g c a g t  4 9 7 1  
t l
c c c c a c t g a t t c t t c c c a c a g g c t t a g t c c c a g t c t c t g t c c a c g t g g g a g c a g g g g a t c a c a g a g g  5 0 3 8
c g t g t c t c c c a a t a g c t g t g t g t g t g g a c t g g g a g g a t c t a c t g c c c a g g a t a a g g a c t g c a g c t c a  5 1 0 5
P s t I
e t g c a c c a c g c a a a a t c a g g e c t g g c t g g t g c t x t g g c g t a g t g g a c t t c c c a c c t g t a c c g c t t c t  5 1 7 2
P v u I I
g a t c a g c t c c c t g c t g a t g g c c t g g g g a a g c a g c g x e a g a t g g c c c a g g t g c t t g g g c c c t g c a c c c  5 2 3 9
a c a t g g g a g a c c t g g c t g a a g c t c c t g c t t c a g c c t g g t c c a g c c c t g g c c a t t g t g a c c a t t t g g g  5 3 0 6
g a g t g a a c c a g c a g a t g a a a g a t c t c t c t c t c t c t c t c t c t c t c t c t c t c t c t c t c t c t c t g e c t c t  5 3 7 3
g c t t t t c c c t c t c t g a a a c t c t g a c t t t a a a a t a a a t a a a c c t t t a a a a a a a g a a a a a a t c a g g c c t  5 4  4 0
t t g t c c c a a a & a g c c t g g c a e a t c t g g g t g t c t g g a t t c t g t g c a c a g t a g a a g a g a & a c c t a g c a g  5 5 0 7
g c c g g c g c a c a g c t c a c t a g g c t g a a t c c t c c a c c t g t g c g c c g g c a c a c t g g g t t t a g t c c c g g t t  5 5 7 4
g c t c c t c t t c c a g g c c a g c t c t c t c c t g t g g c c c g g g a x g a g t g g a g g a t g g t c c a g c t g g t t g g s c  5 6 4 1
S m a l  P v u I I
c c t g c a c c t g c a t g g g a c a c c a g g x g x a a g t g c c t g g c t c c t g g c t t c g g a t c g g c g t g t g t g t g c t  5 7 0 8
g g c c a t a t a g t g c c t a g c g g c a c t t g g g g g a t a c a t g a a a — - <  9 0 0  b p  > - - c t c g a t a c c g t . t  6 6 6 0
g a a c B c K a t c a a g g t c c g a g a a a a g a g a c a g g c c c c g t a c c c o t t t c t t a c c t g a a t t g t g t g t t c t  6 7 2 7
g t g t t g a g t c g t e t c a t  t c c t t c t a t a t t c a t t t c t . c a a a a a a g f t a a t g c a g g t g g g c a a c a a a t a n  6 7 9 4
c a a a a a c a t g c t c g g t a c c  —  < 4 0 5  b p --> ---------------------------------- g a g c c t c a c  7 2 2 7
K p n l
t g g g c t g a t a c c t t c c g t c t g a g t g a a g c g a c c t B t t c a g t g a c c t r c a g a a a g c g g t g a g a c a c t g  7 2 9  4
g t t t g g a n c a g g a t t a a t g c g t g t g c g t g t g c a c o o t t g g c a c c c t  t g t g c c g c a c n t  t c g c a c a a t  g  7 3 6 1
c c c a c a c e c t t c c t e r t g c  t g g a g a t g a g c a g g c a c c c t  g t g c c c t c c t c c t c t c t g t  g t  c a  t t g c c  7 4 2 8
t g c g a c g t c c t t g g c c t l g g c t c g c t r e e t r c t a g a a t e g g c t c c a g g t t t g c t t c t l r t  tgtrag/  7 4 9  4
EXON 5 
4 2
l y  L y a  l i e  T h r  A l a  G l u  G l u  A l a  T h r  A r g  S e r  S e r  T y r  L e u  A s n  H e  V a l
CT AAG ATC ACA GCC GAG GAG GCC ACA AGO TCC AGC TAC CTG AAC ATC GTG 7 5 4 4
G l y  L e u  v a l  G l y  S e r  l i e  A a p  A s n  A s p  P h e  C y s  G l y  T h r  A s p  M e t  T h r  H e
GGC CTG GTC GGC TCC ATT GAC A AT GAC TTC TGC GGT ACG CAT ATG ACC ATC 7 5 9 5
G l y  T h r  A s p  S e r  A l a  L e u  H i s  A r g  l i e  T h r  G l u  H e  V a l  A s p  A l a  l i e  T h r
GGC ACC GAC TCT GCC CTG CAC CGG ATC ACA GAG ATT GTG GAT GCC ATC ACC 7 6 4 6
1 9
T h r  T h r  A l a  G i n  S e
ACC ACA GCC CAC A G  7 6 6 0
INTRON 5
/g  t a c a c a c t a t g a c g g g c a g a a g a g c t g g g g c c t c g t g g g t g a a g t g a a g t c t t t g a g c t g t g g t g  7 7 2 6
a c t g a t g g c c & g t t t c c t g g g g c t g g t a t g c t & t t t t t a g c t g c a a g t g a t t c c t a g & g c g t a g g & a  7 7 9  3
9 8
t g g c a c t g g t c c c t a a g c a c t g t g a g a t t t g c c t t t t g c c a c c t a c c a g c c t c c t g t g c t g c a t g t g  7 6 6 0t
g c t c c t g g g c c c g c c t t t g c a g c c a t c t g g t g g g g t g g c c t g t g t g c g g g t g t a a g t g c t j r t c t c t c  7 9 2  7
tcttgoag/  7 9 3  5
EXON 6
7  2 1
r  H i s  G i n  A r g  T h r  P h e  V a l  L e u  G l u  V a l  M e t  G l y  A r g  H i s  C y s  C l  
C  CAC CAG AGG ACA TTT GTG T T A  GAA GTG ATG GGC CGC CAC T G T  GG  7 9 8 0
INTRON 6
/gtaaggt.ccccgtcct------------------------------    < 2 3 6  b p  > - --------  — --------------   8 2 3 2
- - - - - - - - - - - - - - - - - - - a c g c t a t g g c a a g t g g g t g t g a g t a a g g a a g g t c t c c t c a g g a g c c a g  8 2 8 0
c g a t c t g a c c t c a c c c t g a g g t g a c a o a c a g g a t c t g c a g a c c t t c c c a g c t g t g g c a c c c g a a g a g  8 3 4 7
2 6
t t t g c t g c g t c t g g g g a g c c t g t t g a g £ g g t g c a g c L c t g a g t g g g £ t g c c c t # g c t c t c t c t c a j r /  84  13
*
EXON 7  
2
y  T y r  L e u  A l a  L e u  V a l  T h r  S e r  L e u  S e r  C y s  G l y  A l a  A s p  T r p  V a l  P h e
A TAC CTG GCC CTG GTC ACC T C T  CTG TCC TGC GGT GCT GAC TGG GTC TTC 8 4 6 2
H e  P r o  G l u  C y s  P r o  P r o  A s p  A s p  A s n  T r p  G l u  A s p  H i s  L e u  C y s  A r g  A r g
ATT CCT GAG TGT CCT CCG GAT GAC AAC TGC GAG CAT CAC CTG TGT CGC CGG 8 5 1 3
2 4 8
L e u  S e r  G l u
CTC ACT GAC  8 5 2  2
INTRON 7
/ t f f c g c  t g c a t  g e t  t a t c c t . t g c a g g a c a i « c c c t g t r c « t g t c t g e a g B t  t e a t  t t g c t c x g t  r t  a c  8 5  8 6
 ------------------------------------------------------- -- j o  b p  > - - ------ --------------------------------------------------- -------------------  8 6  29
5 2  2 3
 g a g t g a t t a a g a t c c a a c a t g e t g e a r t g g c f i c a g t c c t e a t g c t g r t  t ctctgcxtgaccag/  8CyL
31
EXON 8  
2 4 9
T h r  A r g T h r A r g G l y S e r A r g L e u A s n H e l i e H e V a l A l a G l u G l y A l a
ACA CGG ACC CGT GGC T C T CGC CTC AAC ATC ATC ATT GTG GCC GAG GGT GCA
l i e  A s p  A r g
ATC GAC AGG

























GAT 8 7 8 8
/ f f t t a j r t g t B c a g g a a g c t g a g g g g c c c t a g c a t g g s g g c c c c e g a a t a t t c c c t a g t g g t t c t g t ' g  8 8 3 4
t c t c c c c a a g t c c c t g c c t g t c a t t c c c t c t g c a c c a c g a a c c a c t a t g g a c a a g g g g c c c a g c g t t  8 9 2 1  
3 6  2 7
c c t g g t c a g c e c a g t e c c c t t g a c t c a g c a g a c c c c t c t g t g t t f c t tggtcccctoBg/ 8 9 7 9
* t
EXON 9  
2 8 1
L e u  V a l  V a l  A r g  A r g  L e u  G l y  T y r  A s p  T h r  A r g  V a l  T h r  V a l  L e u  G l y  H i e
TTG OTG GTG AGA CGT CT G  GGC T AT  GAC ACG CGG G T T  ACC GTC C T G  GGG CAT 9 0 3 0
3 1 1
V a l  G i n  A r g  G l y  G l y  T h r  P r o  S e r  A l a  P h e  A a p  A r g  H e  L e u
GTG CAG CGA GGT GGA ACC CCC TCA GCC TTC GAC AGG AT C  CTG 9 0 7 2
B a e H I
I N T R O N  9
/ t f t , g a g f c c a c a g g c t c t g t g g c c c c t g £ a x c a t c a g a a t t g t c t g c a c c t t  < 6 0 0  b p  > - - g  9 7 2 4
S
a g c t c t t a g c a g c a g t g a t g t t g a t t g a g a t g g t g t t c c g t c t c a g c c c t t e c c a c t t g c a t g g a g g  9 7 9 1  
s t l
g g a g a g g c g a g t c a g a t g g g g a a t t t g t t t c t c c g g a a c c g a g g a g a a c c t t g g t t t g a t a g g g a g c  9 6 3 8
g g a c a a g t g a c t c a g c t t g a g g t g t g a c t g t a g g g a g g g a c a g c a a t c t g c t g c t a g c c t t c a t g t g  9 9 2 5
a t n c a g t a t g a a g c a g c g t £ c a g c t c t c a g t g g a c t o g a t g c a g c a c t g c a a t t t c t g c t t < 2 1 b p >  1 0 0 0 7  
3 9  21
c t g c a g c a t c t c t g a g t c g g t t t c c t c a t c t g t a a a a t g t t c c t g a g g a g g a c a ^ a ^ i c c t g c a g /  1 0 0 7 3  
P s t I  * * p Bt I
EXON 1 0  
3 1 2
G l y S e r A r g M e t G l y V a l G l u A l a V a l M e t A l a L e u L e u G l u G l y T h r P r o
GGC AGC AGG ATG GGC GTG GAA CCA GTG ATG GCG CTG T T G GAG GGG ACC CCG 1 0 1 2 4
A s p T h r P r o A l a C y s V a l V a l S e r L e u S e r G l y A s n G i n A l a V a l A r g L e u
GAC ACC CCG CCC TGT GTG GTG AGC CTG TCT GGT AAC CAG GCC GTG CGC CTG 1 0 1 7 5
3 5 3
P r o L e u M e t G l u C y s V a l G i n V a l
CCG CTC ATG GAA TGT GTC CAG GTG 1 0 1 9 9
I NT R O N 1 0
/ t f t a a g t c c a g c c c o g c e c t  t c c a a a g g c c a a a c c c g t c t c a g a g c a t  g g g g a g a g g t x c r t  t c c g g  1 0 2 6  5
cxtgtcagagaagt---< 2 1 7  hp >-----ctgacncagtaattccactgttaactcatreagac 1 0 5 3 1
a g c a t t c t g a a a a t g c t g a t g c t t g a g o a c g c g c c t g c c c c c a g a g c a c a g a g c a c a g c g c a g c t g c  1 0 5  98
Pvul I
t g a a a a t g c c c c c c a c c c c t g c t g c t t c c t c a g a c t c g g t c t c t c g a c t g t c t c t a t c a e a g a a t t c  1 0 6 6 5
EcoRI
g g g g a a a g c t g c g g c a g c t g c t t c c c c t g g g c t g t c t g t g g g g t c t t c c t x a t t c g c t c c c c c t t c t  1 0 7  32  
P v u I I
t t a t t g a g g c c a c g t g a a g c t g g g a t t g g g t g t g g a g c c a g g g a g a t g c g g g c a c g g c c c c c t c c c c  1 0 7 9 9
g t g g t t c t g a a t a g a g c a t e a g g t t g c c c t t t t c t g t t g c t a c t e a t t a c t c a g a a a g t t a g g g a g a  1 0 8 6 6
a t a a a g g t e a c t t c t c t g a a a g t t t t g g a g a c a t c a g a a a g g t g g a g t g c a c c t t t c t c g a g c a g g g  1 0 9 3 3
2 9
a c g g g c a g g c t g g t g g g t g g a a g g c a g c c c t g c c c t g a g c c t t g c c c t a c t c t g ' c f c e c t c c c t c a g ’/  1 0 9 9 9
*
EXON 11  
3 5 4
T h r  L y s  A s p  V a l  T h r  L y s  A l a  M e t  A s p  G l u  L y s  A r g  P h e  A s p  G l u  A l a  M e t
ACC AAA GAT GTG ACC AAG GCC ATG GAC GAG AAG AGA TT T GAT GAA GCC ATG 1 1 0 5 0
37
L y s  L e u  A r g  G l y  A r
AAG CTG AGA GGC CG 1 1 0 6 4
INTRON 11
/ f  t g a * £ f e a a t g a c c a g a c c a g c t g a c g a g a a a t g a g a t g a c c a g g g ~ - --------------------- ------------------- 11110
P v u I I
< 2 9 7  b p  >caaagtctgcctggctccataccBaagcaggagcttctgccccctccccttcetccc 1 1 4 6 4
t g c c a c a g c t t c t g c c c a g c a c a g a t g g c t c a g t c c t c t c c t g g c c a t t c t t c t g g c t c t a g g c g a g  1 1 5 3 1  
1 1 6
g g g c c a g c t c t g t c g t g a t g a g c a a g g g c c c g g g a g g a g a g t g c g c B g g g a g c Q t g t g a a g g a g g a g  1 1 5 9 8  
* Smal
g c c c c t c t g c a g c c c c g c t c t g c c t g c t g c g c a g g g g a a t g g g c t g a a g a c a c t  t e a t t t t c a c a * /  1 1 6 6  4 
P s t I
EXON 12  
5
g  S e r  P h e  M e t  A s n  A s n  T r p  G l u  V a l  T y r  L y s  L e u  L e u  A l a  H i s  H e  A r g
G AGC TTC ATG AAC AAC TGG GAG GTG TAC AAG CTT CTG GCT CAC ATC AGA 1 1 7 1 3
3 9 6  H i n d l l l
P r o  P r o  A l a  P r o  L y s
CCC CCA GCC CCC AAG 1 1 7 2 8
INTRON 1 2
/ t f  t a c g a a c a a c g f i g g c g c c c e t c a o t c t t t c c c t . c c c c a c e c t C B g t C P c a c c t a a g c c t t  c ~ c a g  1 1 7 9 4
c c t g t g t g c a a c g c t g e t c t c a g t t c c a c c g g g c g g t t t t c t  t c t  t g g c c a c c c a g a t c c t  g g c c c *  1 1 8 6 1
g t g t t c t t B g t g t g t c c c g g a t g t e t c t g a c c c t t g r c c B g t c t g f t f i c a g r c a t g c B K t K g a < - « ; c R c  11 9 2 8
aagaggtgtctg tgc t. ttuccctc t ggcnaccaatCHcat gcgcrocgacaggagcagagg t d  cgt 1 1 9 9  5
g t  t g g a g c c c c c g a a f n c a c a c g t g a R r t g a t g g g g t  t g g t c t t  R g g g c e g c g g g g r t c c g g a g R g g  1206 2 
8 3
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Figure 9. Gel electrophoresis to identify Ml3 clones containing the N- 
terminal of rabbit muscle PFK gene. A 0.5 kbp PvuII fragment selected 
by hybridization od lambda Charon 4A/pfk to synthetic N-probe was 
subcloned into the Smal site of M13mpl8, phage particles were first 
selected for insertion by their lac phenotypic change. Two positive 
clones were finally chosen and tested. (A) Mini-screen of RF DNAs. 
Two positive M13RF DNAs prepared as described in MATERIALS and METHODS 
were digested with EcoRI and Hindll. The digests were subjected to 
electrophoresis on 0.7% agarose gel and stained by ethidium bromide. 
M13mpl8 vector DNA was digested with the same enzymes and run on lane 3 
as the control. Lane 1, clone 1; Lane 2, clone2. The open arrow 
indicates a 0.5 kbp fragment on lane 1 and 2 but not 3. (B) Direct gel
electrophoresis. Positive M13 phages supernatant were treated as 
described in MATERIALS and METHODS and subjected to electrophoresis on 
0.7% agarose gel and stained by ethidium bromide. Hindlll and EcoRI 
digests of lambda DNA and M13mpl8 phage supernatant treated as 
described in MATERIALS and METHODS were run on lane 1 and 2 as size 
markers. Lane 3, clone 1; lane 4, clone 2. (C) Complementary test.
Positive Ml3 phages supernatant were treated as described in MATERIALS 
and METHODS. Lane 1, Hindlll and EcoRI digests of lambda DNA; lane 2, 
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Figure 10. Schematic representation of a new strategy for rapid DNA 
restriction mapping.
electrophored and then gel will be dried on gel drier and expo­
sed under an X-ray film overnight at room temperature. C, D and 
E represent restriction enzymes used for partial digest; M, the 
size markers, band 1, vector with target DNA; band 2, vector DNA 
only; band 3, intact target DNA; band 4 and the dotted line on 
the gel bottom represent the short labelled polylinker, which 
will run off the gel.
Figure 11 showed the gel electrophoretic patterns and the 
derived restriction maps of the two DNA fragments purified from 
RMPFK gene. The wild type lambda DNA was first used to titrate 
different restriction endonucleases to find the best condition 
for partial digestion (data not shown). The Hindlll and EcoRI 
digests of wild type lambda DNA were labelled as the size mark­
ers at 5’ end. 103 to 106 cpm was previously loaded on a 1.2% 
agarose gel to quantitatively check the counts needed to show 
clearly on autoradiogram (data not shown). The data showed that 
104 cpm for each band was satisfactory. After exposure, the 
dried gel was soaked and stained by EtBr. The EtBr stained gel 
pattern was compared with autoradiogram to obtain a quatitative 
idea of how much DNA corresponded to each 104 cpm band. The 
units of restriction enzyme used for partial digestion could 
therefore be determined by counts of labelled DNA. For example, 
35 ng corresponded to 104 cpm and 104 cpm was used for each 
reaction, thus 0.035 units enzyme was added to satisfy the con­
dition of the partial digestion.On panel A, a 4.5 kbp KpnI/EcoR]
SrQjamB S |'J-ili IJ (VXSsWVP ILIU.L.J...] I J
4,8 Kbp J 2,5 Kbp~~1
Figure 11. Rapid mapping of restriction sites in the 4.5 and 2.5 kbp 
DNA fragments of rabbit muscle PFK gene. All the reaction conditions 
were described in MATERIALS and METHODS. The principle was described 
in RESULTS. (A) Rapid mapping of a 4.5 kbp fragment of PFK gene. 
M13mpl8 RF DNA containing a 4.5 kbp insert was partialy digested with 
restriction enzymes. The digests were subjected to electrophoresis on 
1.2% agarose gel. Hindlll and EcoRI digests of wild type lambda DNA 
was radioactively labelled at 5* end and run on lane 6 as size markers. 
Lane 1, intact; lane 2, Sail digest; lane 3, SstI digest; lane 4, 
Hindlll digest; lane 5, BamHI digest; lane 7, HincII digest; lane 8, 
Smal digest; lane 9, SphI digest; lane 10, Xbal digest; lane 11, Xmal 
digest. Deduced restriction map is given on bottom. (B) Rapid mapping 
of a 2.5 kbp fragment of PFK gene. M13mpl9 RF DNA containing a 2.5 kbp 
insert was partially digested with restriction enzymes. The digests
were subjected to electrophoresis on 1.2% agarose gel. Size markers 
was treated as described in (A) and run on lane 8. Lane 1, intact; 
lane 2, Sail digest; lane 3, SstI digest; lane 4, Hindlll digest; lane 
5, BamHI digest; lane 6, PvuII digest; lane 7, PstI digest; lane 9, 
HincII digest; lane 10, Smal digest; lane 11, SphI digest; lane 12, 
Xbal digest; lane 13, Xmal digest. The deduced restriction maps are 
given on bottom.
38
fragment in M13mpl8 was analyzed. The top band corresponding 
7.2 kbp came from vector part, the second band corresponding 4.5 
kbp represented the intact target DNA.By comparing the digestion 
pattern of Xmal (lane 11) with Smal (lane 8) and HincII (lane 7) 
with Sail (lane 2), each enzyme pair showed same recognition 
sequence. On panel (B), a 2.5 kbp fragment in M13mpl9 was 
analyzed. Preliminary data (not shown) revealed that target DNA 
did not have Kpnl site. Kpnl was therefore chosen to linearize 
the recombinant DNA. The top band represented the target DNA 
with vector. Its size is about 9.7 kbp. Because the complete 
DNA sequences and restriction map of M13mpl8 and mpl9 are known 
(Yanisch-Perron et al., 1985), some of the restriction endo­
nucleases having restriction sites in polylinker can still be 
used by this strategy. For example, M13mpl8 has three PvuII 
fragments; 6834, 322, and 93 bp. If these fragments are excluded 
from the autoradiogram pattern, the other fragment should come 
from target DNA. On panel (B) lane 6 (PvuII cut), the pattern 
showed the accessibility. The detailed restriction map of rabbit 
muscle PFK gene (Figure 12(B) ) was established by using this 
new strategy.
3. Subcloning of PFK fragments into Ml3 and pER vectors.
All the EcoRI, EcoRI/PstI, PstI, PvuII, EcoRI/PvuII frag­
ments, were subcloned into Ml3 and pBR by shotgun cloning. The 
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Figure 12. Genomic organization and sequencing strategy of rabbit 
muscle PFK gene. (A) Genomic organization. Exons are shown as boxes 
(see below for further definitions) drawn in approximate scale. Num­
bers above indicate the number of amino acid residues encoded by each 
exon. Exons are indicated by numbers in order from the N- to C-termi­
nal of the encoded protein. The solid boxes indicate exons encoding
nucleotide binding sites; open boxes, exons encoding sugar binding 
residues; crosshatched boxes, exons encoding substrate ATP binding 
sites; hatched boxes, exons encoding residues without assigned func­
tions. The arrow labelled N-half spans exons encoding the amino-half 
of the protein while the C-half arrow spans exons encoding the carbox­
yl-half of the protein. (B) Restriction map Sites are: B=BamHI, E=Eco- 
RI, H=HindIII, K=KpnI, S=SalI, Sm=SmaI, Sp=SphI, Ss=SstI, X=XbaI, solid 
triangles=PstI, and open circles=PvuII. (C) The sequencing strategies
are grouped as restriction fragments, Bal-31 ordered sequencing, and 
synthetic primer sequencing.
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were subcloned into Ml3 by forced cloning. Figure 13 shows the 
results of Dot hybridization to screen M13 clones generated by 
shotgun cloning. For example, 8.9 kbp EcoRI fragment digested 
with PstI were subcloned into M13mpl8. One hundred and eighty 
seven clones were chosen and spot on nitrocellulose paper. The 
hybridization results were shown in Figure 13. The strength of 
signal roughly reflected the size of insert. Figure 14 shows 
the hybridization results of pBR plasmid clones. As shown in 
panel (A) and (B), 3 fragments: 2.5 kbp EcoRI, 1.8 kbp and 0.7
kbp EcoRI/PstI fragments were successfully subcloned into pBR3- 
25. This result also showed that 2.5 kbp had only one PstI 
site. Panel (C) and (D) showed that the fragments of 6.0 kbp 
EcoRI, 0.5 kbp EcoRI/PstI, 1.8 kbp PstI were subcloned into 
pBR325. This result also showed that the 6.0 kbp EcoRI fragment 
had at least 5 PstI sites. Panel (E) and (F) showed that the 
fragments of 8.9 kbp EcoRI, 5.0 kbp and 4.0 kbp EcoRI/SalI, 1.8, 
0.5, 1.1, 0.9, 1.3, 0.3 kbp PstI fragments were subcloned into
pBR325. These results also showed that 8.9 kbp fragment had at 
least 8 PstI sites.
4. Probing of exon number and exon positions of rabbit muscle PFK 
gene.
In order to probe the exon number and locate their positions, 
synthetic oligonucleotides were made as described (Matteucci &. 
Caruthers, 1981). The DNA sequence and correspondant PFK posi-
Figure 13. Dot hybridization to screen Ml3 clones generated by shotgun 
cloning of rabbit muscle PFK gene fragments. A 8.9 kbp DNA was puri­
fied from pBR325/8.9 kbp clone and digested with PvuII. The digest 
mixture was subcloned into the Smal site fo M13mpl8. Phage particles 
were selected for insertion by their phenotypic change. One hundred 
and eighty seven putatively positive clones were chosed, spot on nitro- 
celulose paper, and hybridized with the nick-translated 8.9 kbp probe 
as described in MATERIALS and METHODS.
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Figure 14. Southern transfer and hybridization to identify pBR clones 
containing fragments of rabbit muscle PFK gene. DNA fragments gene­
rated by EcoRI, EcoRI and PstI, and PstI digests were subcloned into 
plasmid 325. Plasmid DNAs with inserts selected by their antibiotic 
phenotypic change and toothpicker method (Barnes, 1977) were purified, 
digested with restriction enzymes as described in MATERIALS and ME­
THODS. A, C, and E were the digestion pattern stained by ethidium 
bromide. Plasmid DNAs containing inserts from 2.5 kbp EcoRI fragment 
were subjected to A, from 8.9 kbp EcoRI fragment were subjected to C, 
and from 6.0 kbp EcoRI fragment were subjected to E. Size markers were 
run on lane 1 on A, lane 1 and 3 on C, and lane 1 and lane 4 on E. (A) 
lane 1, size markers; 2 and 3, pBR325/2.5 kbp, 2 was digested with 
EcoRI and PstI, 3 was digested with EcoRI; 4, pBR325/1.8 kbp, digested 
with EcoRI and PstI; 5, pBR325/0.7 kbp, digested with EcoRI and PstI 
(C) lane 1 and 3, size markers; 2, 4, and 5, pBR325/6.0 kbp, 2 was
digested with EcoRI and SstI, 4 was digested with EcoRI and PstI, 5 was 
digested with EcoRI. 6 and 8, pBR325/0.5 kbp digested with PstI and
EcoRI; 7, pBR325/1.8 kbp, digested with PstI. (E) Lane 1 and 4, size 
markers; 2, pBR325/5 kbp, digested with EcoRI and Sail; 3, pBR325/4
kbp, digested with EcoRI and Sail; 5 and 6, pBR325/8.9 kbp, 5 was
digested with EcoRI and PstI, 6 was digested with EcoRI; 7, pBR325/1.8 
kbp, digested with PstI; 8, pBR325/0.4 kbp, digested with PstI; 9,
pBR325/l.l kbp, digested with PstI; 10, pBR325/0.9 kbp, digested with 
PstI; 11, pBR325/1.2 kbp, digested with PstI; 12, pBR325/0.3 kbp,
digested with PstI. Gels were blotted, hybridized with nick-translated 
lambda Charon 4A/pfk probe as described in MATERIALS and METHODS. B, 
D, and F indicating the hybridization results were arranged site by 
site for each gel.
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tion were shown in Figure 15. To clarify the digestion pattern, 
the gel was blotted and hybridized with vectors. In Figure 
16(A), the blot was hybridized with the nick-translated wild 
type lambda DNA; in (C) the blot was hybridized with the nick- 
translated pBR325 DNA. From the results of panel (A), we
excluded bands from lambda 4A. From the results of panel (B), 
we excluded bands from pBR325. It is interesting to note that 
among these DNAs, there is no significant homology. Therefore, 
it is convenient to use the nick-translated lambda 4A/pfk DNA as 
probe to screen any library containing the PFK gene fragment, 
and to avoid the tedious steps to isolate pure fragment from 
gel. In Figure 17, multiple blots were made and hybridized with 
oligonucleotide probes which corresponded to different regions 
of RMPFK. These oligonucleotides also represent different exons. 
EcoRI/PstI or EcoRI/PvuII digested lambda 4A/pfk DNA were loaded 
on lanes 1 and 7 as the positive control. The results of PFK1 
probe on panel (B) showed a 1.7 kbp PstI and a 0.5 kbp PvuII 
bands. This result reveals the location of the first exon. The 
results of PFK1.5 probe on panel (C) showed a 1.8 kbp PstI band. 
In the same way, a 3.0 kbp PstI band hybridized with PFK 2 
probe; a 1.2 kbp PstI band hybridized with PFK 4 probe; a 0.5 
kbp Pstl/EcoRI band hybridized with PFK 7 probe. It was demon­
strated again that the 0.5 kbp PvuII fragment contained the N- 
terminal of the gene; while the 0.5 kbp Pst/EcoRI fragment 
contained the C-terminal of the gene. In this way, 10 exons
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Figure 15. Corresponding positions of synthetic oligonucleotides and 
cDNA probe in RMPFK. The sequence for each synthetic oligonucleotide 
was described in MATERIALS and METHODS. The number in the right margin 
correspond to the sequence from the first amino acid residue (number 
with 1) to the last amino acid residue (number with 779) of rabbit 
muscle PFK. The arrow indicates the 3’ end of each DNA sequence. The 
solid line under the sequence indicates the corresponding position of 
cDNA probe and N-probe used to determine C- and N-terminal of PFK gene. 
The solid arrow head indicates the first amino acid of N- and C-halves 
of the protein. The solid triangles represent the introns. The italic 
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Figure 16. Southern transfer and hybridization using nick-translated 
vector DNAs. 3 EcoRI fragments of rabbit muscle PFK gene; 2.5 kbp, 8.9 
kbp, and 6.0 kbp, were subcloned into the EcoRI site of pBR325 respec­
tively. Plasmid pBR325 DNAs with different insert were purified as 
described in MATERIALS and METHODS and digested with EcoRI and PstI or 
EcoRI and PvuII. The digests were electrophoresed on a 1.2% agarose 
gel, blotted and hybridized with nick-translated pBR325 DNA oe wild 
type lambda phage DNA. (B) Gel electrophoresis of digests, lanes 1 to 
4 represent the PstI digest, whereas lanes 7 to 10 are PvuII digest. 
Haell digest of pBR322 DNA and Hindlll and EcoRI digests of lambda DNA 
were run on lanes 5 and 6 as size markers. Lanes 1 and 7, lambda 
Charon 4A/pfk; lanes 2 and 8 , pBR325/2.5 kbp; lanes 3 and 9, pBR325/8.9 
kbp; lanes 4 and 10, pBR325/6.0 kbp. (A) Blot was hybridized with 
nick-translated wild type lambda phage DNA, (C) Blot was hybridized 
with nick-translated pBR325 DNA.
Figure 17. Southern transfer and hybridization to probe the exons 
numbers and positions using synthetic oligonucleotides. Oligonucleo­
tides were synthesized and purified as described in MATERIALS and 
METHODS# DNA sequence and corresponding protein position were also as 
described in APPENDIX 4. Oligonucleotides were radioactively labelled 
at 5’ end with T4 DNA Kinase. (A) Gel electrophoresis pattern as des­
cribed in Figure 16(B). (B) Blot was hybridized with PFK 1. (C) Blot
was hybridized with PFK 1.5. (D) Blot was hybridized with PFK 2. (E)
Blot was hybridized with PFK 4. (F) Blot was hybridized with PFK 7.
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were found and localized unambiguously along the restriction map 
of PFK gene.
5. Sequence analysis of rabbit muscle PFK gene.
As shown in Figure 8 and Table 2, 71% of the DNA sequence
of rabbit muscle PFK gene has been determined. These data 
include the sequence of all exons, 67% of the sequence of 
introns, 61 bp in the 5’ flanking region, and 584 bp in the 3’ 
flanking region. The promotor, cap site and polyadenylation 
signal of this gene are not yet identified. The DNA sequence 
shows that 7 bPs upstream of the translation initiation codon 
ATG is an C/T rich region followed by a sequence of TAG, a 
typical 3’ splicing junction sequence. This result indicates
there is an additional intron in the 5' untranslated region of 
the PFK gene (Chung et al., 1985). An Alu consensus sequence ( 
CCAGCCTGG ) was found at the 3* flanking region (nucleotides 
16479-16487), while 3 pairs of direct repeats with sizes 155, 
394, and 130 bp respectively were found (Figure 8 ). These data 
indicate a Alu-like sequence at the 3’ flanking region (Schmid & 
Jelinek, 1982). No tKNA gene or Kpnl short repeats were found 
in both coding and noncoding region (data not shown), however, a 
variety of short repeating sequences were noted. These include 
(TC)ig at nucleotides 5329-5367 and a nearly continuous T track 
at nucleotides 222-282 (Figure 8 ).
The consensus of splicing junction (Breathnach & Chambon,








E 1 82 27 I 0 8 8
E 2 74 25 I 1 3500
E 3 78 26 I 2 300
E 4 190 63 I 3 350
E 5 166 55 I 4 3000
E 6 45 15 I 5 275
E 7 109 36 I 6 500
E 8 96 32 I 7 170
E 9 93 31 I 8 191
E10 126 42 I 9 1 0 0 0
Ell 65 2 2 1 1 0 800
E12 64 2 1 1 1 1 600
E13 150 50 1 1 2 433
E14 71 24 113 300
E15 8 8 29 114 207
E16 153 51 115 165
E17 165 55 116 316
E18 62 2 1 117 740
E19 1 1 2 37 118 168
E20 1 0 0 33 119 836
E21 106 36 1 2 0 73
E22 142 47 1 2 1 2 1 0
Total
2 2 exons 2337 b..p. 779 A.A.s 2 2 introns 14782 b.p.
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1981) are obeyed at the 5’ and 3’ termini of each intron (Table 
3). A second consensus sequence near the 3’ end of each intron 
(Keller & Noon, 1984; Ruskin et al., 1984) complementary to its 
own 5' end and considered to be the sequence of branch site was 
also present (Table 4). These sequences are the ones that best 
satisfy the criteria of complementarity and location (within 70 
bases of the 3’ end), with the exceptions of intron 3, 5, and 
11. The possible Lariat branch site in each intron is not 
unique; for example, two possible branch sites were found in 
introns 7, 8 , 9, 15, 20, and 21. These branch sites were also 
indicated in Figure 8 by asterisks.
The four bases are not in equal molar amounts for both 
overall and coding sequences as shown in Table 5. The coding 
sequence has an even higher C+G content (59%), while the overall 
sequence has 57% in G+C content. The result of high G+C content 
matches the results of the high PstI and PvuII sites observed in 
Figure 12(B).
The results of dinucleotide percentages in the gene are 
shown in Table 6 . Considering the high G+C content, we should 
not be surprised to see the low percentages of AT, AA, TA, and 
TT. However, the deficit of dinucleotide CG, a well established 
characteristic of eukaryotic genes (Nussinov, 1981), is evident 
in this gene. The ACC triplet coding for the first residue; 
theronine, immediately follows the ATG codon. The termination 
codon TAA immediately follows the last valine codon GTC. A
Table 3. Nucleotide sequences present at the splice junctions of 
the rabbit muscle PFK gene. The 5' and 3’ terminal sequences of 
each intron are shown between the two arrows that define the 
splicing sites; they are flanked by the terminal sequence of the 
respective exons. The underlined sequences agree with the consen­
sus (Breathnach & Chambon, 1981).
4r I
GAG GTGGCT I  0 --------------------  TCTTGCCTTCTAGAG T 3
AAG GTAAGG I  1 --------------------  TCACTGTCCCCGCAG G
GAG GTCAGT I  2 --------------------  AGCTATATCCCACAG G
CTG GTAGGT ---------------------- I  3 --------------------CCICnTOGTCAAAG G
CGG GTGAGA I  4 --------------------GCircrrCTTGTCAG G
GAG GTACAC I  5 --------------------GICTCTCTCTTGCAG C
TGG GTAAGG ---------------------- I  6 --------------------CIGGCTCTCTCTCAG A
GAG GTGCTG I  7 --------------------  TCTCTGCXTGACCAG A
GAT GTTAXT I  8 --------------------  GCTTGGTCCCCTCAG T
CTG GTGAGT ---------------------- I  9 --------------------  ACAGAGGICCTGCAG G
CTG GTAAGT 110 --------------------  CTGCTCCTCCCTCAG A
COG GTGAGG 111 --------------------  ACTTCATTTTCACAG G
AAG CTACGA 112 --------------------  GACTATGTAGAGTAG A
CAG GTATGG 113 --------------------GGCCmTCCTGCAG A
AAG GTGAGC 114 --------------------  CTCCGGTOCAACTAG G
GAG GTGAGT , 115 --------------------CTGCTCTCCCGTCAG G
ACG GTGCAG ---------------------- 116 --------------------  TCCCOGTGCCTGCAG A
CAG GTAGAC ---------------------- 117 -------------------- AAdTTGGCnTCAG G
GAG GTACTG --------- 118 --------------------  GGCOCTCCCTGGCAG G
CAG GTATGC / 119 --------------------GTAATTCTmTCAG G
ACG GTAGGT --------- 120 --------- ggtgggtgattgcag G
TGA GTGAGT 121 -------------------- CICATTCTTCTGTAG G
Consensus Sequence
C A TTTTTTTTTTT T
5’ AAG GTGAGT----------XVS CCCCCCCCCCCNCAG G 3’
T  t
Table 4. Possible Lariat branch sites in the rabbit muscle PFK gene.
The top row of each set of paired sequences represent the 5’ splice 
junction. The arrow indicates the splicing junction. The complemen­
tary sequence (shown on the second or third row) occurs near the 3’ end 
of the same intron; the exact distance from the 3' splice site is 
indicated by the number below the base A which is the potential Lariat 
site. Underlined sequences indicate complementarity (column 2) or
agree with the consensus sequences (column 4 and 5) including G-T 
wobble pairs.
Keller Buakin «t ml. 
ft Noon Comeneua 
Consensus T T C T
Intron Sequense at Branch Site Gese Burins CTGAC QJCTAAC
1 o
i
3' GATCTCOCTC GAG 5' 
5' CTCTCCTAAC JGA 3’ 
26
7/13 GfAAC TCCTAAC
I 1 3* AOGAGGAATO gaa S' 
5* CAOCCCTGAC TCI 3' 
" 56
6/13 CTGAC CCCTGAC
1 2 3’ CCCTTGACTC GAO 5’ 5' CGAOGCTGAC OGG 3' 
21
8/13 CTGAC OOCIGAC
I 3 S' GTCTTGGATC GTC 5’ 
5' XXCAGCTCAC TCA 3’ 
96
7/13 CTGAC AOCTGAC
1 4 3f GTACAGACTG CCC 5* 
5' TCTgTCTCAT TOC 3’ 
72
9/13 CTCftT GTGTCAT
1 6 3* ATCACACATG GAG 5* 
5‘ JJGCCAOCTAC CAG 3' 
98
6/13 GCTfiC CACCTAC
I 6 3' OCCTGGAATC COT 5‘ 
6’ CAOCTCTCAG TOC 3* 
26
6/13 CTGAC CTC1GAG
1 7 3’ CTACCTCGTC CAG 5’ 
5* TCATIAAGAT CCA 3* 
52








1 8 3* CCTCTXATTC TAG 5’ 
51 TUXXTTGAC TCA 3‘ 
3b








I 9 3' ACACTGAffTC GTC 5' 
5' CITianCAT CTC 3'
39








110 3* GACCTGAATG CTG 5’ 
5’ CTUCCCTGAG CCT V  
29
8/13 CTGAG CCCTGAC
111 3* taaaggagtg a c c  s1
5’ CTGTCGTGAT GAO 3* 
116
7/13 gtgat TCCTCAT
112 3’ AACAAGCATO GAA 5’ 
5' AGAOCCTCAT CTG 3‘ 
83
5/13 CTCAT SC T C 4I
113 3’ TCAAGOTATG GAC 5* 
5' OCAOjgCC4C CCA 31 
52
6/13 QCCAC GJCCCAC
114 3’ COGAOGAGTG GAA 51 
5’ TTCCCTTGAT JJC 3’ 
49
7/13 TEAT CTS4T
115 3’ ACTOTGACTG GAG 5’ 
5’ TT£GG(*TCAI OCC 3’ 
87








116 3 ’ CCGACACGTC OCA 5 ' 
5 ’ QATCCAAAAT GAC 3 ' 
26
5/13 A&AAT JEAA4AT
117 3 ' AGAACAGATG GAC S' 
5’ ctttocccac icc 3* 
37
8/13 0XAT IQSOCAg
118 3’ CGACGTCATG GAG 5 ' 
S' grOOpCTGAC GAA 3' 
81
4/13 CCCTGAC
119 S' CTCOCCTATG GAC 5' 
5' GCAICJSGAT TfC 3 ’ 
83
7/13 T0G4T 5 3 0 W
X20 3 ' QOGATOGATC OCA 5 ' 
5 ’ QUTOCAGAG OCT 3 ’ 
42








121 3' CACGTGACrrc ACT 5' 
5' CJTCCCATAA OCT 3‘ 
54








Table 5. Nucleotide percentages in rabbit muscle PFK gene
A C G T C + G A + T
overall 20 28 29 23 57 43
coding 22 27 32 19 59 41
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Table 6. Dinucleotide percentages in rabbit muscle PFK gene.
Italic numbers represent the percentage for the overall PFK gene, 
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2.3 6.9 9.1 4.7
similar arrangement was reported for the cDNA of rabbit muscle 
creatine phosphokinase (Putney et al., 1984).
The amino acid sequence of the rabbit muscle PFK was revis­
ed and completed from the coding sequence as shown in Figure 15. 
The first ATG codon triplet codes for the initiation methionine 
residue which is post-translationally removed. The revised PFK 
has a calculated molecular mass of 84975 daltons and the compo­
sition of 779 amino acids. Our amino acid sequence agrees with 
that reported by Poorman (Poorman et al., 1984) except for four 
positions of discrepancy (Figure 15): an arginine instead of a 
serine at amino acid 268 (number the first amino acid Thr with 1 
and the last amino acid Val with 779) a proline instead of a 
leucine at amino acid 442, a serine instead of an isoleucine at 
amino acid 558 and an additional arginine at amino acid 565. 
The amino acid composition is shown on Table 7. The high C + G 
content (~60%) of coding sequence reflects that the predominant 
codons end in C or G for amino acids Ala, Arg, Asn, Asp, Pro, 
Ser and Thr (Table 8 ). This result is consistent with the chara­
cteristic prevalence of G+C in many mammalian genes (Nussinov, 
1981).
The 3’ portion (nucleotides 12915-12977) of exon 15 and the 
5’ region (nucleotides 13143-13166) of exon 16 together code for 
an amino acid sequence of 29 residues (Figure 15, amino acids 
479-507). The helix-probability and hydrophobicity profiles of 
these 29 amino acid residues are shown in the hatched areas of
Table 7. Amino acid compositions and percentages of rabbit muscle PFK
AA Number Num% Wt%
Ala 65 8.3 5.4
Arg 54 6.9 9.9
Asn 30 3.9 4.0
Asp 39 5.0 5.3
Cys 15 1.9 1.8
Gin 24 3.1 3.6
Glu 47 6.0 7.1
Gly 82 10.5 5.5
His 19 2.4 3.1
He 46 5.9 6.1
Leu 60 7.7 8.0
Lys 38 4.9 5.7
Met 22 2.8 3.4
Phe 29 3.7 5.0
Pro 24 3.1 2.7
Ser 43 5.5 4.4
Thr 56 7.2 6.7
Trp 10 1.3 2.2
Tyr 15 1.9 2.9
Val 61 7.8 7.1
Length of amino acid sequence is 779. 
Molecular weight is 84975.
56
Table 8. Codon usage in the coding sequence of rabbit muscle PFK gene
N C Total N C Total N C Total N C Tot;
Ala GCA 3 5 8 Arg CGA 4 3 7 Asn AAT 3 5 8 Asp GAT 11 2 13
T 6 7 13 T 5 2 7 C 8 14 22 C 14 12 26
G 3 6 9 G 10 5 15
C 21 14 35 C 4 3 7
AGA 5 1 6
G 5 7 12
Cys TGTT 6 2 8 Gin CAA 1 3 4 Glu GAA 6 5 11 Gly GGA 6 3 9
C 3 4 7 G 8 12 20 G 17 19 36 T 9 1 10
G 7 12 19
C 20 24 44
His CAT 4 1 5 He ATA 1 1 2 Leu TTA 1 0 1 Lys AAA 3 6 9
C 8 6 14 T 5 5 10 G 3 2 5 G 10 19 29
C 15 19 34 CTA 0 2 2
T 1 1 2
G 22 18 40
C 7 3 10
Met ATG 11 11 22 Phe TTT 2 7 9 Pro CCA 1 1 2 Ser TCA 2 2 4
C 9 11 20 T 2 4 6 T 5 2 7
G 5 1 6 G 1 0 1
C 3 7 10 C 5 7 12
AGT 4 2 6
C 8 5 13
Thr ACA 6 1 7 Trp TGG 5 5 10 Tyr TAT 1 0 1 Val GTA 1 1 2
T 2 6 8 C 5 9 14 T 3 4 7
G 3 6 9 G 22 13 35C 20 12 32 C 11 6 17
Figure 18. A similar pattern of one alpha-helix followed by a 
fl-sheet observed in BsPFK was demonstrated. The high hydropho­
bic property of these 29 residues (as shown in Figure 18(B)) 
agrees with Kemp’s observation (Kemp, personal communication). 
Furthermore, an oligonucleotide probe; gap 3 (Figure 15), was 
shown to hybridize to the northern blot of rabbit muscle mRNAs 
(Valdez, personal communication). These data show that these 29 
amino acids residues fit the undetermined gap (Poorman et al., 
1984). Thus, our nucleotide sequence for this gene has completed 
the entire amino acid sequence of rabbit muscle PFK.
More importantly, the identification of a phenylalanine at 
amino acid 498 and a glutamic acid at amino acid 499 excludes 
the C-half of this enzyme from a role in binding of substrate 
ATP (Poorman et al., 1984; Hellinga & Evan, 1985).
6 . Genomic organization of rabbit muscle PFK gene.
The rabbit muscle PFK gene in lambda phage clone is 17 
kilobase pairs in length, within the two flanking EcoRI cloning 
linkers (Figure 12(C) ). There are 18 PvuII sites and 14 PstI 
sites but only two EcoRI sites and two Hindlll sites (Figure 
12(C)). The exon number and exon positions of this gene as 
shown in Figure 12(B) were established by comparing its DNA 
sequence with the amino acid sequence (Poorman et al., 1984) and 
localizing the fragments along the restriction map by hybridiza­
tion. The size of the exons ranges from 15 codons (exon 6 ) to
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Figure 18. Comparison of the helix-probability and the hydrophobicity 
patterns in PFKs. (A) Comparison of the helix-probability pattern. 
The plots are based on the sequence presented on Figure 3. Helix- 
probability (Phil) are taken from Mattice et al. (Mattice et al., 1980) 
and averaged over a length of 10 residues. The representation of 
BsPFK, RMPFK (N), and RMPFK (C) are as same as in Figure 3. The posit­
ions of 13 alpha-helix structural elements of BsPFK are also indicated 
by numbers. (B) Comparison of the hydrophobicity pattern. The plots 
are based on the sequence presented on Figure 3. Hydropathic index are 
taken from Kyte and Doolittle (Kyte & Doolittle, 1982) and averaged 
over a length of 10 residues.
63 codons (exon 4). These exons can be grouped into three 
classes by size: 10 "50" bp; 11 "140" bp and 1 "200" bp. The 
abundant classes are 50 bP and 140 bp sequences. These results 
agree with the statistics of higher eukaryotic genes (Naora & 
Deacon, 1982). Approximately, 8 6% of the cloned gene is occu­
pied by introns. Individual introns vary considerably in size 
from 73 to 3500 bp, although short introns ranging from 200 to 
400 bp in length are more abundant (Table 2). The map in Figure 
12(A) clearly shows that introns in the N-half region are much 
longer (up to 3500 bp) than those in the C-half region (73 to 
836 bp). Thus, the 12 exons encoding the N-half of the protein 
are scattered over 13 kbp while the ten exons encoding the C- 
half of the protein are clustered in a length of 4 kbp.
The majority of the introns are positioned between or near 
the ends of the secondary structural elements as shown in Figure 
19(A). It is also noted that the coding sequences for alpha- 
helices 6 , 8 , 9, and 11 are interrupted by introns. Based on
Poorman’s model (Poorman et al., 1984) that the RMPFK subunit 
resembles a head-to-tail linked dimer of BsPFK, a hypothetical 
tertiary structure for RMPFK is shown in Figure 19(B). When the 
sites of introns shown in Figure 19(A) are overlaid on this 
model, the image shows that the positions of these introns are 
on the surface of the N- and C-domains of the protein. Figure 3 
shows four regions in the rabbit muscle PFK sequence standing 
out as "extra" residues (italicised) when the bacterial PFKs and
Figure 19. The positions of introns in the structure of rabbit muscle
PFK. A. Position of introns along the secondary structural elements 
based on the structure of BK stearothermophilus PFK. Arrows located 
above indicate position of introns in the N-half of rabbit muscle PFK 
gene, Arrows pointing from the bottom are the C-half introns. B. 
Projection of intron positions on the three-dimensional structure of 
rabbit muscle PFK )based on the crystallographic structure of EK stea- 
rothermophilus PFK (Evans and Hudson, 1979) and amino acid sequence 
homology between these two proteins). The schematic drawing is viewed 
along the x-axis. The large open arrows represent B-sheet strands (A- 
K) and cylinders represent alpha-helices (1-13). The N- and C-halves 
are joined by a connecting peptide (dashed lines). The small arrows 
point to the positions of introns in the gene sequence (modified from 
Evans and Hudson, 1979 with permission)
the two halves of rabbit muscle PFK are aligned for sequence 
homologies. Introns interrupt the coding sequences in each of 
these four regions. It seems likely that these "extra" amino 
acid residues were inserted by intron slide shuffling as propos­
ed by Gilbert (Gilbert et al., 1986).
II. Techniques developed in this work
1. Making of strand and length specific probes.
A new technique was developed to make the strand and length 
specific probes. Figure 20(A) shows the restriction map of 6.0 
kbp EcoRI fragment of RMPFK gene. It also indicates the posi­
tion of 2.5 kbp fragment. On panel (B), lane (2) and (3) showed 
that circular vector was linearized but the reaction was not 
completed, lane (5) showed that a band migrated to the position 
between 1.6 kbp and 2.0 kbp. Although the digested lambda DNA 
was run on the same gel as markers, the corresponding size might 
not reflect the real size of single stranded DNA fragment. When 
the gel was blotted and hybridized with a nick-translated 2.5 
kbp probe, it showed that the band came from a 2.5 kb insert. 
Figure 20(D) showed that all the radioactively labelled single 
stranded probes migrated to the same position and corresponded 
to the original 2.5 kb position (Figure 20(C)). The probes 
made by 3 different ways were used to hybridize different blots. 
In Figure 21, the probe made by 5’ end labelling specifically 
hybridized to the 2.5 kb but not 3.5 kb and the size markers. 
In Figure 22, the probe made by 3’ end labelling hybridized to 
the dot blot homogeneously no matter how different the insert 
sizes were. In Figure 25, the probe made by primer extension 
with Klenow showed that the probe specifically hybridized to the 
complementary single strand genome but not the vector DNA.
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Figure 20. Making of strand and length specific probes from a 2.5 kb 
single stranded insert. Single stranded phage DNA from M13mpl8 clone 
containing a 2.5 kb insert was prepared as described in MATERIALS and 
METHODS, annealed respectively or together with the synthetic 29 mer 
and 2 0 mer which were complementary to each end of the polylinker 
region of M13mpl8 (sequence as described in MATERIALS and METHODS), and 
then digested with EcoRI and HindiII. 1% low melting point agarose gel 
was electrophored, blotted, Hybridized with the nick-translated 2.5 kbp 
fragment as described in MATERIALS and METHODS. Single stranded DNA 
corresponding to 2.5 kb was isolated and purified from gel. Probes 
were made by 5’ and 3’ end labelling or primer extension of single 
stranded phage as described in MATERIALS and METHODS. (A) Schematic 
representation of the restriction map and the position of 2.5 kbp 
fragment. (B) Lane 1, lambda DNA digested with EcoRI and Hindlll as 
size marker; lane 2, single stranded phage DNA; lane 3, single stranded 
phage DNA annealed with 20 mer and digested with EcoRI; lane 4, single 
stranded phage DNA annealed with 29 mer- and digested with HindiII; lane 
5, single stranded phage DNA annealed with 20 mer and 29 mer, and then 
digested with EcoRI and Hindlll. (C) Southern blot and hybridization 
with the nick-translated 2.5 kbp fragment. (D) Making of strand and 
length specific probes. Lane 1, single stranded phage DNA was annealed 
to Ml3 universal 17 mer, extended with Klenow fragment, and then diges­
ted with Hindlll. The labelled DNA was denatured before subjected to 
gel electrophoresis. Lane 2, purified 2.5 kb single stranded DNA was 
labelled at 5' with T4 DNA Kinase end as described in MATERIALS and 
METHODS. Lane 3, purified 2.5 kb single stranded DNA was labelled at 
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Figure 21. Southern transfer and hybridization using strand and length 
specific probes. Single stranded phage DNAs containing insert with 
different length were digested with EcoRI and Hindlll as described in 
Figure 20 and subjected to 0.8% agarose gel, blotted, hybridized with a 
5’ end labelled probe generated as described in Figure 20. (A) Gel
electrophoresis of the digests of single stranded phage DNAs. Lane 1, 
Hindlll and EcoRI digests of lambda DNA as size markers; Lane 2, di­
gests of phage DNA with a 2.5 kb insert; Lane 3, digests of phage DNA 
with a 3.5 kb insert. (B) Southern blot and hybridization with the 5’ 
end labelled probe made from the 2.5 kb DNA.
Figure 22. Dot hybridization using strand and length specific probe.
A Ml3 library was generated by shotgun cloning of PstI digest of 6 kbp 
fragments from rabbit muscle PFK gene. Ninety clones with insert were 
selected by their phenotypic change. Phages supernatant were spot on 
nitrocellulose paper and hybridized with the 3’ end labelled probe from 
2.5 kb single stranded DNA as described in MATERIALS and METHODS and 
Figure 20.
2. Unidirectional nested DNA sequencing.
Figure 23 show the schematic representation of the improved 
unidirectional nested sequencing strategy. RF DNA with insert 
subcloned into A and B sites of polylinker is purified as described 
in MATERIALS and METHODS. RF DNA is digested with restriction 
enzyme A, trimed with exonuclease Bal-31 for various time interva­
ls, and digested with restriction enzyme B and X, while vector DNA 
is prepared by multiply digests with restriction enzymes B, C, and 
Y. C will create a blunt end, whereas B creates a cohesive end. 
The purpose to digest with restriction enzymes X and Y is to reduce 
the possibility of self-ligation of insert to vector and vector by 
itself. The digests are pooled and an aliquot is used to ligate 
with digested vector with T4 DNA ligase and then transformed into 
JM 107. Phage particles on plates with appropriate numbers are 
transferred to nitrocellulose paper and hybridized with nick-trans- 
lated probe. Phage SS or RF DNA with various length of inserts are 
prepared as described in MATERIALS and METHODS. SS DNA or RF DNA 
are sequenced using Ml3 universal sequencing primer or reverse 
sequencing primer as described in MATERIALS and METHODS. A Ml3 
library created by using this improved strategy was screened by in 
situ hybridization. The results were shown in Figure 24. Fifty 
positive ones were shown on the dish having a total 55 phage parti­
cles including 50 white ones, while 100 positive ones were shown on 
the dish having a total 105 phage particles including 100 white 
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Figure 23. Schematic representation of an improved unidirectional 
nested DNA sequencing strategy.
Figure 24. In situ hybridization of Ml3 clones containing the Bal-31 
treated fragments of rabbit muscle PFK gene. A 2.5 kbp, EcoRI/SstI DNA 
fragment purified from the pBR325/6.0 kbp clone was digested with PstI, 
subcloned into the polylinker of M13mpl8. Phage particles with insert 
were selected by their lac phenotypic change. RF DNA purified as des­
cribed in MATERIALS and METHODS was digested with EcoRI, trimmed with 
exonuclease Bal-31 and subcloned into the Sstl/HincII sites of M13mpl8 
as described in RESULTS. After transformation, fresh phage particles 
on petri dishes with the numbers from 50 to 100 were selected, blotted, 
hybridized with the nick-translated 2.5 kbp probe as described in 
MATERIALS and METHODS. (A) A dish with a total 55 phage particles and 
50 white ones. (B) A dish with a total 105 phage particles and 100 
white ones.
enzyme resulted a low background in transformation. Eighteen 
positive clones were selected randomly lysed by SDS and subjected 
to gel electrophoresis. The results on Figure 25(A) showed that 
all the inserts ranged within 2.5 kbp in size. When the blot was 
hybridized with the strand and length specific probe, it further 
demonstrated that all of the inserts showed the same polarity and 
came from the same 2.5 kbp fragment (Figure 25(B)). Template DNAs 
from these 18 clones were purified and sequenced. DNA sequence was 
analyzed by computer. Results was shown in Figure 12(C). It 
showed that DNA sequences were well overlapped and continuous.
Figure 25. Southern transfer and hybridization of single atranded M13 
clones generated by Bal-31 using strand and length specific probe. (A)
Eighteen M13 clones (lane 2 to 19) generated as described in Figure 24 
were selected, lysed, subjected to 0.4% agarose gel electrophoresed and 
then stained by ethidium bromide as described in MATERIALS and METHODS. 
Single stranded M13mpl8/2.5 kbp and M13mpl8 were mixed, lysed, and run 
on lane 1 and 20 as size markers. (B) The phage DNAs were trainsferred 
to nitrocellulose paper, hybridized with the probe generated by primer 
extension of single stranded M13mpl8/2.5 kbp as described in RESULTS.
DISCUSSION
I. EMFFK gene DNA sequence, genomic organization and gene evolution
1. Is rabbit muscle PFK evolved from a prokaryotic progenitor by 
gene duplication and divergence?
Mammalian PFKs have been speculated to have evolved from a 
prokaryotic progenitor gene by gene duplication and divergence 
(Poorman et al., 1984). This speculation is based on the com­
parisons of RMPFK and BsPFK. If we accept this speculation, two 
criteria should be met: (1) the PFK gene is composed of two 
duplicated halves and (2) these two halves are not only similar 
each other, but also similar to the BsPFK gene. To evaluate the 
first, criterion, we first focus on the relation between the exons 
of the gene and the functional domains of this protein. Binding 
sites in rabbit muscle PFK are classified into two types: the 
catalytic sites including sites binding substrate F6P and sub­
strate ATP, and effector sites including those for the binding of 
activators ADP and FBP and inhibitor ATP (Poorman et al., 1984, 
Ilellinga and Evans, 1985). We have grouped these sites as sugar 
binding sites including sites binding F6P and FBP and nucleotide 
binding sites such as ADP activation sites and ATP inhibition 
sites. Sites for binding substrate ATP are grouped separately 
for the sake of clarity. When the amino acid residues of the 
enzyme are labelled with these designations (Figure 3, boxed 
residues), it becomes noticeable that these sites form subdomain, 
each enclosed within an exon. With few exceptions, almost no
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introns are found to interrupt these subdomains. More striking­
ly, when the exons in the map (Fig. 8) are identified by their 
encoded subdomains a clear pattern of gene duplication is reveal­
ed. The organization of exons in the N-half of the gene is dupli­
cated in the C-half. Exon 13 corresponds to a fusion of exons 1 
and 2 while exon 17 represents a fusion of exons 6 and 7. Exon 4 
contributes only substrate ATP binding sites while exon 15 con­
tains the corresponding diverged residues. The order of exon 21 
and 22 appears to be an inversion of exons 11 and 12 or vice 
versa. This inversion is possibly due to the loss of an intron 
between Lys-324 and Ile-325 in C-half (Figure 3). Based on the 
duplication pattern, the number of exons in N-half is the same as 
that of the C-half (Table 9). Although the length of the introns 
separating the exons are quite different in the two halves (Table 
2), the size of these corresponding exon pairs is indeed similar 
in this gene (Table 9). The homology (43%) of the coding sequence 
between these two halves is even higher than the homology (30%) 
of protein sequence (Table 10). Futhermore, two halves show a 
similar predominant codon usage (Table 8). The evidence discussed 
so far fit the first criterion that the RMPFK gene is composed of 
two duplicated halves.
At the protein level, it has been shown that the N-half of 
RMPFK is more similar to BsPFK as compared to the C-half (Poorman 
et al., 1984; also see Table 10). However, by DNA sequence com­
parison (Table 10), our results suggest that the C-half of RMPFK 
is more similar to BsPFK. Nevertheless, both N- and C-halves of 
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Table 10. The DNA and amino acid homology comparison of related 
PFKs. Amino acid homology is shown by italic number and DNA 
homology is shown by regular number.
EcPFK BsPFK RMPFK(N) RMPFK(C)
EcPFK 53 39 30
BsPFK 57 42 33
RMPFK(N) 47 43 30
RMPFK(C) 43 48 43
level. The evidence from the comparisons of DNA sequences satis­
fy the second criterion that the two halves of RMPFK gene are not 
only similar each other, but also similar to BsPFK gene. The data 
so far discussed support the hypothesis that mammalian PFK gene 
evolved from a prokaryotic progenitor and divergence.
2. Intron/exon organization of RMPFK gene.
Gilbert (Gilbert, 1978) proposed that introns divide genes 
into exons which might correspond to structural or functional 
domains in the final proteins. Recombination within introns 
could assort these functions independently. Individual exons 
could be thought of as building blocks; a single block might be 
duplicated and used several times in one or more genes. Our 
results show that most introns of RMPFK gene are localized be­
tween or at the ends of the secondary structural elements (Figure 
19) and each exon represents a functional subdomain ( Figure 
12(A) ). There are two extreme views for the origin of intron. 
Doolittle (Doolittle, 1978) proposed that introns were in the 
preexisting gene. This hypothesis is based on the assumptions;
(1) a splicing apparatus existed in the first cells and (2) in­
trons were lost from prokaryotes as their genomes became stream­
lined under the selective pressure of rapid DNA replication, 
while introns were retained in eukaryotes. Contrastly, Orgel and 
Crick (Orgel and Crick, 1980) proposed that introns were laterly 
added at some point to break up preexisting genes. The latter 
hypothesis is on the assumption that prokaryotic genes resemble 
the preexisting genes and that the addition of introns and the
occurrence of splicing apparatus emerged later during the evolu­
tion of eukaryotic genes. However, the demonstration of RNA 
self-splicing events in tetrahemena by Cech (Cech, 1986) and the 
finding of similar exon/intron motifs in triose phosphate iso- 
merases from different sources by Gilbert and his coworkers ( 
Gilbert et al., 1986) have made the first hypothesis more attrac­
tive and acceptable. If we accept Doolittle's hypothesis, we 
should see similar exon/intron motifs for the two halves of RMPFK 
gene. However, our results are contrary to this prediction. 
Introns on the C-half of this gene are not located at identical 
positions as those in the N-half (Figure 3). This result suggests 
that duplicated two halves may not have identical exon/intron 
motif, because intron position may be changed due to intron dele­
tion or recombination (Gilbert et al., 1986). Furthermore, muta­
tion at splicing junctions would result splicing to use other 
cryptic splicing junctions; these junctions are inactive before 
mutation (Ruskin et al., 1984). This migration and change of 
intron position result part of intron sequences being exon 
sequences after splicing. This added exon sequences would then 
code extra amino acid residues in the final protein product. 
There are four regions in the rabbit muscle PFK sequence which 
stand out as extra residues (Figure 3) when the two halves of 
RMPFK are aligned with two bacterial PFK sequences for maximum 
homology. All these four extra regions have intron to interrupt 
the sequences. These results agree with our suggestion that these 
extra amino acid residues evolved from intron sequences and the 
migration of splicing junctions over evolution time.
3. Tissue-specific codon usage in RMPFK gene.
Newgard and his coworkers (Newgard et al., 1986) reported 
that cDNAs of glycogen phosphorylase from liver and muscle exhi­
bited a remarkable divergence in G+C content at the third codon 
positions (86% to 60%). They further surveyed other mammalian 
cDNAs and found that this bias in codon usuage patterns in liver 
and muscle was in general. This finding leads to the suggestion 
that codon usage may play an important role in specific gene 
expression of tissues. RMPFK gene has 75% of codons have G or C 
at the third codon position (Table 8). These results support 
that this gene so far discussed are the one encoding muscle PFK 
rather than other isozymes.
4. Full-length cDNA and isozyme genets): from known to unknown.
The catalytic and allosteric sites of RMPFK so far referred 
are deduced from the crystallographic structure of BsPFK (Poorman 
et al. , 1984). To construct a full-length cDNA to verify those
putative sites using site-directed mutagenesis approach seems to 
be an unavoidable way. However, several attemps to make the 
full-length PFK cDNA failed due to unknown reasons (Vora et al., 
1986; French, personal communication; Valdez, personal communica­
tion). In addition to the sequences of all exons, we also report 
the restriction sites and possible secondary structure in this 
coding sequences (Figure 26). This coding sequence in turn
represents the mRNA of rabbit muscle PFK gene and this informa­
tion will be very helpful to construct a full-length cDNA. 





<  > < * * >
GCTCTTCTTCCTCCATGAGGGCTACCAGGGCCTGCTGGATGGCGGGCACCACATCCCQGAGGCCACCTGG
< ♦ ♦♦♦ ♦ > (
GAOAGCGTCTCCATGATGCTGCAGCTTJGUAGGCACCGTGATTGGAAGTGCTCGGTGCAAGGACTTCCGGG 280




i — -----♦«-— ----->
AAAGCCGCTAAGATCACACCCG/.GGAGGCCACAACGTCCACCTACCTGAACaTCGTGGGCCTGGTCCGCT 490
CCATTGACAATGACTTCTGCGGTACGGATATOACCATCGGCACCGACTCTGCCCTGCACCGGATCACAGA 560 
>< +  > <------ ♦
GaTTGTGGATGCCATCACCACCACACCCCAGAGCCACCAGAGGACATTTGTGTTAGAAGTGATGOGCCOC 630
♦ ♦ — — -> <   >
< ♦+++ )
CACTGTGCATACCTGGCCCTGGTCACCTCTCTGTCCTGCGCTGCTGACTGGGTCTTCATTCCTGAGTGTC 700 
<-— +♦------>---------------------------------------- <— -+♦---- >
CTCCGGATGACAACTGOGAOGATCACCTGTGTCGCCGCCTCAGTOAOACACGGACCCGTGGCTCTCGCCT 770




<  > < ♦ ♦♦♦ >
GACCCCCGACACCCCQGCCTGTGTGGTGAGCCTGTCTGGTAACCAGGCCGTGCGCCTGCCGCTCATQGAA 1050
< -----♦ ♦ ♦ ♦ ♦ — _>
TGTGTCCAGGTGACCAAAGATGTGACCAAGGCCATGGACGAGAACAGATTTGATGAAGCCATGAAGCTGA 1120
GAGGCCGGAGCTTCATGAACAACTGGGAGGTGTACAAGCT7T:TGGCTCACATCAGACCCCCAGCCCCCAA 1190 
< ♦ ♦ ♦♦ >
►  C-HALF
GAGTGGCTCGTACACCGTAGCTGTGATGAACGTGGGTGCCCCGGCGGCAGGCATGAATCCAGCTCTTCGC 1260 <---- ♦ + ♦ + ♦--- > <--
TCCACTGTGAGCATTCGCCTGATCCAGGGCAACCCGGTGCTGGTGCTGCaCGATGGCTTCGAGGGCCCTG 1330
< ♦  > <   > < ♦♦  >
<....««« > < ♦
CCAAGGGCCAGATTGACGAAGCCGGCTGGACCTACCTAGGGGGCTGGACCGGGCAAGGCGGCTCCAAACT 1400
M  7 0 
<
CAGGGCCTGGTCATCATTGGGGGCTrTGAGGCTTACACCCGGGGCCTGGAGCTGATGGAGGGCAGCAAGC 1540
< ♦♦♦* ) <- —  ♦ ♦  )
 +  > < —  ♦ -><     >
AGTTTGACGAGCTCTGCATCCCTTTCGTGOTCATCCCTGCCACAGTCTCCAACAACGTTCCCGGCTCAGA 1610
CTTCAGCGTCGGGGCGGACACGGCGCTCAACACCATCTGCACGACGTCTGACCGTATCAAGCACTCCGCA 1680<-- ♦-> < *<--♦ +->
GCGGGCACCAAGCGCCGGCTCTTCATCATCGAGACCATGCGCGGCTACTGCGGCTACCTGGCCACCATGG 17 50 
 > <------ ♦ —  > — ♦♦---->
CAGGACTGGCAGCCGGGOCCGATGCTGCCTACATTTTTGAOGAGCCCTTCACCATCCGAGACCTGCAQGC 1820
< +  > <--♦ ------->
<--- - ♦ ♦ ♦ ♦ — -->
GAATGTTGAACACCTGGTGCAAAAGATCAAGACGACTGTGAAGAGAGGCTTGGTGCTCAGGAACGAGAAG 1890








<— -_♦ + ♦♦♦— __>--------------------------<-- —  ♦ +---- >
2310
TCCCGAAAACCGTCTGGGGAAGCCACCGTC TAA 2343
BasHI / COATCC : 929 Pvull
Hlndll I / AAGCTT : 1156 8«al
Patl / CTGCAQ : 229, 1813, 2176 Sail
/ CAGCTO : 232, 1250
/ CCCGGG : 137
/ GAGCTC : 1549
Figure 26. The possible secondary structural position in the coding 
sequence of rabbit muscle PFK gene. The numbers in the right margin 
correspond to the sequence from the first codon ATG (number with 1) to 
the termination codon TAA (number with 2343). The solid arrows 
indicate the first codon for N- and C-halves of the protein. Sequences 
of restriction sites are indicated by italic and listed on the bottom. 
Secondary structures were computed by using Staden program (Staden, 
1980). The loop size was set from 0 to 5, stem size was set at 5. The 
angled brackets spaned the region of possible secondary structure. "+" 
indicates the loop sequence and region.
Ml3 and pBR vectors. These gene fragments will serve as inva­
luable probes for other PFK isozyme genes (or pseudogenes).
5. Rabbit muscle PFK: from DNA to protein.
The amino acid sequence of the rabbit muscle PFK is revised 
and completed from the DNA sequence (Figure 8). The first ATG 
codon triplet codes for the initiation methionine residue which 
is immediately followed by the threonine residue. This NH2 - 
terminal methionine residue will be cleaved from the nascent 
polypeptide by an aminopeptidase (Yoshida & Lin, 1972). Our DNA 
sequence shows that there is no leader peptide in this protein. 
Moreover, no matter with or without the initiation methionine 
residue, matured RMPFK still retain a stabilizing residue in the 
first NH2 -terminal position according to the N-end rule (Bachmair 
et al., 1986). The long-lived property predicted from the N-end 
rule is consistent with the stable property as observed (Uyeda, 
1979; Foe & Kemp, 1986). High percentages of non-charged amino 
acid residues (Ala, Gly, Leu, Thr, Val) (Table 7) reflect rabbit
muscle PFK has a pi close to pH 8.0 (Uyeda, 1978; Kemp, 1986).
This pi explains why rabbit muscle PFK is stable at pH 8.0 but 
unstable at lower pH (Uyeda, 1979; Foe & Kemp, 1986).
II. Techniques developed in this work
1. Rapid mapping strategy and applications.
DNA fragment inserted into a polylinker of phage or plasmid 
vector can be rapidly mapped for their restriction sites. In the 
beginning of this project, the 17 kbp rabbit muscle PFK gene were
mapped by 13 restriction endonucleases using this new strategy. 
Our DNA sequence has proved the correctness of this map. It is 
evident that this method is simple and direct. No steps for 
purification of DNA fragment from gel are needed. Another advan­
tage is that once the restriction map of the insert is worked 
out, DNA sequencing can be carried on by Maxam-Gilbert (Maxam & 
Gilbert, 1977) or dideoxy sequencing (Sanger et al., 1977) method 
without further subcloning. However, this method also suffers 
the limitation: only enzymes which have the restriction sites in 
the polylinker can be used, except a few cases (ex. PvuII). 
Otherwise, the fragments coming from the vector part will inter­
fere the interpretation of autoradiogram.
2. A technique to make strand and length specific probes and its 
applications.
We have developed a technique for making the strand and 
length specific probes. These probes have been successfully used 
to screen the M13 libraries and proved to be very specific. This 
technique can be applied to isolate full-length single stranded 
DNA for SI mapping, viroid study or site-directed mutagenesis.
3. The advantages of the improved nonrandom DNA sequencing strategy.
This strategy has been proved to possess the following 
advantages:
(1) It is not necessary to isolate Bal-31 trimmed fragments 
from gel.
(2) Multiple digestions greatly . decrease the possibility of
self-ligation of the insert with original vector or the new 
vector by itself.
(3) If M13 phage loses either the origin of replication or 
the gene II sequences, it won't be viable. This characteristic 
provides a good automatic screening system. Each viable white 
phage particle theoretically represents a positive clone.
(4) DNA sequence will be read from a predefined end and 
strand. This will dramatically decrease time and difficulties 
from computer analysis.
(5) Both single stranded and double stranded template can be 
used for bidirectional sequencing.
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0.5 M EDTA (pH 8.0)
1 M MgCl2 
1 M MnCl2





5 M KOAC (pH 4.8) 
(Solution III)
20xSSC
Dissolve 121.1 g Tris base in 800 ml of 
HsO. Adjust pH to the desired value by 
adding concentrated HC1. Adjust final 
volume to 1 1 , sterilize by autoclaving.
Add 186.lg of disodium ethylene diamine 
tetraacetate.2H*O to 800 ml of Ĥ O. Stir 
vigorously on a magnetic stirrer. Adjust 
pH to 8.0 with NaOH. Adjust final volume 
to 1 1. Sterilize by autoclaving.
Dissolve 203.3 g of MgCl2 .6H20 in 800 ml 
of H20. Adjust volume to 1 liter, steri­
lize by autoclaving.
19.791 g/100 ml in IfcO, sterilize by fil­
tration .
Dissolve 408.1 g of sodium acetate.3H20 
in 800 ml of IbO. Adjust pH to 5.2 with 
glacial acetic acid. Adjust of volume to 
1 liter. Sterlize by autoclaving.
57.81 g/100 ml 
filtration.
in H2 0. Sterilize by
0.1 M NaCl, 10 mM Tris-HCl (pH 7.8), 1 mN 
EDTA
50 mM glucose, 25 mM Tris-HCl (pH 8.0), 
10 mM EDTA, 5 mg/ml lysozyme (add lyso- 
zyme powder right before use).
0.2 N NaOH, 1% 
ly).
SDS (use and made fresh-
To 60 ml of 5 M potassium acetate add
11.5 ml of glacial acetic acid and 28.5 
ml of HaO. The resulting solution is 3 M 
with respect to potassium and 5 M with 
respect to acetate.
Dissolve 175.3 g of NaCl and 88.2 g of 
Tri-sodium citrate in 800 ml of H20. 
Adjust pH to 7.0 with a few drops of 





10 N NaOH 
10% SDS
Homogenization buffer




1 M Tris-acetate (pH 7.8) 
1 M KOAC
Dissolve 210 g of NaCl, 27.6 g of Naik - 
PO4 .H2O, and 7.4 g of EDTA in 800 ml of 
H2O. Adjust pH to 7.4 with NaOH. Adjust 
volume to 1 liter.
Add 1 g of ethidium bromide to 100 ml of
H2O. Stir on a magnetic stirrer of
several hours to ensure that the dye has 
dissolved. Wrap the container in alumi­
num foil or transfer to a dark bottle and 
store at 4°C.
To a bottle containing 500 g of TCA, add 
227 ml of H2O. The resulting solution
will contain 100% (w/v) TCA.
200 g/500 ml in H2O. Store in plastic 
bottle.
Dissolve 100 g of electrophoresis-grade 
SDS in 900 ml of H2O. Heat to 68°C to
assist dissolution. Adjust pH to 7.2 by
adding a few drops of concentrated HC1. 
Adjust volume to 1 liter.
100 mM Tris-HCl (pH 8.0), 100 mM EDTA,
0.2 M NaCl.
1.7025 g/25 ml in H2O adjust pH to 6.8.
10 mM Tris-HCl, 1 mM EDTA (pH 8.0)
100 mM Tris-HCl (pH 8.0) 50 mM MgCl2
5 mM Tris-HCl (pH 8.0), 0.1 mM EDTA (pH 
8.0)
(M.wt. 121.14) 12.114 g/100 ml in H20,
adjust pH to 7.8 using acetic acid.
(M.wt. 98.1) 9.81 g/100 ml in H2O, steri­
lize by filtration.
1 M Mg(OAC)2 (M.wt. 214.5) 21.45 g/100 ml in H2O,
sterilize by filtration.
Solution (Antibiotic) Preparation / Composition
Ampicillin Stock solution. 25 mg/ml of the sodium 
salt of ampicillin in 50% ethanol (v/v). 
Store in aliquots at -20°C. Working 
concentration. 35-50 ug/ml.
Chloramphenicol Stock solutions. 34 mg/ml in 100% ethan­
ol. Store at -20°C. Working concentrat­
ion. For amplification of plasmids, 170 
ug/ml; for selection of resistant bacter­
ia , 30 ug/ml.
Tetracycline Stock solution. 12.5 mg/ml tetracycline 
hydro chloride in 50% ethanol (v/v). 
Store at -20°C. Working concentration. 
12.5-15.0 ug/ml. Magnesium ions are 
antagonists of Tetracycline. Use media 
without magnesium salts (e.g., LB) for 
selection of bacteria resistant to Tetra­
cycline. Because tetracycline is light- 
sensitive, solutions and plates contain­
ing the antibiotic should be stored in 
the dark.
Solution (M 13) Preparation / Composition
100 mM IPTG 23.8 mg IPTG/ml in H20 (M.Wt. 238.3)
(isopropyl-B-D-thiogalac- Store at -20°C.
topyranoside)
X-gal 2% solution, 25 mg in 1.25 ml DMSO
(5-bromo-4-chloro-3- Store at 4°C in a dark bottle.
indolyl-B-D-galactoside) 
or Bluo-gal
20% PEG/2.5 M NaCl 20 g polyethylene glycol (PEG-6000), 10 g 
NaCl dissovle in 100 ml distilled H20. 
Store at room temperature.
1 M K-MES (pH 6.3) (M.wt. 195.2), 9.76 g/50 ml in H20 using 
10 M KOH to adjust pH to 6.3, filter, 
store at -20°C.
10 M KOI! (M.wt. 56.11) 56.11 g/100 ml in H20. 
Store in plastic bottle.
1 M RbCl (M.wt. 120.9) 3.025 g/25 ml in H20,
filter, store at -4°C.
0.25 M HAC0CI3
TFB (Transformation buffer)
(M.wt. 267.46) 6.687 g/100 ml in H2O,
filter, store at -4°C.
10 mM K-MES (pH 6.3), 100 mM RbCl, 45 mM 
MnCl2 .4H20, 10 mM CaCl2 .2H20, 3 mM HACo-
CI3 , filter, store at 4°C.
FSB (Frozen storage buffer) 
2.25 M DTT
B-Mercaptoethanol
Add 10% glycerol in TFB.
(M.wt. 154.3) 347 mg/1 ml 40 mM KAC (pH
6>0> , filter, store at -20°C.
Usually obtained as a 14.4 M solution. 






Dissolve 60 mg of ATP in 0.8 ml of H20. 
Adjust pH to 7.0 with 0.1 M NaOH. Adjust 
volume to 1.0 ml with ILO. Dispense the 
solution into small aliquots and store at 
-70°C.
Dissolve NTP or dNTP in Low TE (pH 8.0) 
directly in the shipping bottle at an 
concentrated concentration. Store at- 
70°C.
(M.wt. 471.2 g) 47.12 mg/1 ml in JLO.
final
dATP’ dCTP’ dGTP’ dTTP* concentration
dNTP’ mixes (ul) (ul) (ul) (ul) (mM)
0.5 mM dCTP 300 15 300 300 0.0122
0.5 mM dGTP 300 300 15 300 0.0122
0.5 mM dTTP 300 300 300 15 0.0122
final
Chase solution M.wt. volume (ul) concentrat i on (mM)
20 mM dATP 583 25 0.5
20 mM dCTP 569 25 0.5
20 mM dGTP 609 25 0.5
20 mM dTTP 589 25 0.5













This concentration is for 500 bases of 
sequencing gel.
40% acrylamide stock 380 g/1 acrylamide and 20 g/1 bisacryl-
amideDissolve in H2O with stirring. 
Bring to final volume of 1 1. Filter
through Whatmann 3 MM paper. Store at 
4°C in dark bottle. Stable indefinitely.
10% (w/v) ammonium 1 g APS in 9 ml H2O. Store at 4°C.
persulfate (APS) Stable 1-2 weeks.
10 X TBE 121.1 g Tris-base, 55 g boric acid, 7.4 g
Na2EDTA. Dissolve in H2O. Adjust to 
final volume of 1 1, pH should be 8.3.
Store at room temperature.
Approximate
% poly- 40% Acryl- mobility in
Regular gel acrly- amide stock Urea 10X TBE H2O bases
mix (500 ml) amide (19:1; ml) <g) (ml) (ml) XC BPB
6% 75 250 50 "75 100 30
8% 100 250 50 "150 70 20
12% 150 250 50 "100 45 12
20% 250 250 50 0 25 8
Note:
1. The approximate volume of water is given to aid in 
dissovling the urea. Mix vigorously with a magnetic 
stirrer; avoid heating. Check final volume for 
accuracy. Filter and de-gas the solution. Store at 
4°C in a dark bottle.
2. For a 8% gel and 75 ml gel mix, add 758 ul 10% APS
and 7.5 - 15 ul TEMED (10 minutes for polymeriza­
tion ).
3. For a 20% gel and 150 ml gel mix, add 700 ul 10% APS 
and 25 ul TEMED.
FDE (forma- 0.1% xylene cyanol, 0.1% bromophenol blue, 20 mM EDTA,
mide dye mix) 90% deionized formamide. (Prepare deionized formamide
with MB-1 resin and store at -20°C).
Buffer Gradient Gel 
(0.5X / 2.5X, 6% )
0.5X ( 1 1 )
40% 150 ml
10X TBE 50 ml
urea 470 g (7.8 M)
add H2 0 to 1 1
2.5X 200 ml
40% 30 ml
10X TBE 50 ml
urea 94 g (7.8 M)
40% sucrose 20 g (10%)
bromophenol blue 10 mg
add H2O to 200 ml
0.5X (65 ml) 2.5X (12 ml)
10% A.P. 300 ul 60 ul
TEMED 70 ul 20 ul
Note:
1. draw up in a 25 ml pipette using pipette 
aid: 10 ml 0.5X followed by 10 ml 2.5X and
then let 5 air bubbles to pass interface to 
simply form gradient.
2. Running buffer: IX TBE (prerun 30 minutes)




Solution (Hybridization) Preparation / Composition
50X Denhardt’s Solution Ficoll 5 g 
polyvinylpyrrolidone 5 g 
BSA (Pentax Fraction V) 5 g
H20 to 500 ml
Filter through a Nalgene filter. Dispense
into 25 ml aliquots and store at -20°C.
Prewashing solution 
plaque/colony 50 mM Tris-HCl (pH 8.0), 1 M NaCl, 1 mM 





10X Denhardt’s, 6X SSC, 0.2% SDS, 50 ug/ml 
yeast tRNA.
50% formamide, 5X Denhardt’s, 5X SSPE, 0.1% 
SDS, 100 ug/ml denatured, Salmon sperm DNA.
southern 6X SSC, 0.5% SDS, 5X Denhardt’s, 100 ug/ml 
denatured, Salmon sperm DNA.
Hybridization solution
oligonucleotide probe 10X Denhardt’s, 6X SSC, probe
Nick-translated probe 
plaque/colony 50% formamide, 5X Denhardt’s, 5X SSPE, 0.1% 
SDS, 100 ug/ml denatured, Salmon sperm DNA, 
denatured probe.
southern 6X SSC, 0.01 M EDTA, 5X Denhardt’s, 0.5% 
SDS, 100 ug/ml denatured, Salmon sperm DNA, 
denatured probe.
Medium Preparation / Composition
M-9 salts (10X) 
(minimal media)
60 g Na2HP04 (M. Wt. 131.96), 30 g KHbPĈ  (M. 
Wt. 136.09), 5 g NaCl, 10 g NIP Cl, add I120 to
1 liter.
Mix 20 ml M-9 salts and 3 g of Select Agar in 
approximately 175 ml of water and autoclave to 
sterilize. Cool to approximately 55°-60°C and 
add 0.2 ml 1 M MgSO4 (filter sterilized), 2 ml 
10 mM CaCl2 (filter sterilized), 2 ml 20% 
(w/v) glucose, and 0.2 ml 10 mg/ml thiamine 
(filter sterilized). Adjust volume to 200 ml 
with sterile water and pour into plates ( 
about 10 plates). The plates can be stored 
for several months in sealed bag at 4°C.
NZCYM Medium Per liter:
NZ amine 10 g
NaCl 5 g
yeast extract 5 g
casamino acids 1 g
MgS04 .7H2O 2 g
Adjust pH to 7.5 with sodium hydroxide. 
Bacto-agar 15 g (for plates)
Bacto-agar 7 g (for top agar)
Maltose Maltose (0.2%) is often added to the mediium
during growth of bacteria that are to be used 
for plating bacteriophage lambda, 
maltose 20 g 
add H2O to 100 ml 
Sterilize by filtration.
Add 1 ml of sterile 20% maltose solution for 
every 100 ml of medium.
SM This medium is used for phage storage and




1 M Tris.Cl (pH 7.5) 50 ml
2% gelatin 5 ml
Sterilize by autoclaving and store in 50 ml 
lots.
M-9 agar (200 ml) 
(minimal agar plates)
YT Per liter:
Bacto tryptone 10 g
Yeast extract 5 g
NaCl 5 g
Bacto-agar 15 g (for plate)
Bacto-agar 7 g (for top agar)
LB (Luria-Bertani) Per liter:
Medium -------------------------
Bacto-tryptone 10 g




15 g (for plate)
7 g (for top agar)






RNase A (Free of DNase)
20 mg/ml in H2 O. Store at -20°C.
Preparations of pronase are often contami­
nated with DNase and RNase. These activities 
can be eliminated by incubating the stock 
solution for 2 hours at 37°C.
20 mg/ml in HaO. Store at -20°C.
Stock solution. 50 mg/ml in H2O. Dispense 
into aliquots and store at -20°C. Discard 
each aliquot after use; do not refreeze.
Dissolve pancreatic RNase (RNase A) at a 
concentration of 10 mg/ml in 10 mM Tris.Cl(pH 
7.5) and 15 mM NaCl. Heat to 100°C for 15 
minutes and allow to cool slowly to room 
temperature. Dispense into aliquots and store 
at -20°C.
1000 units/ml RNase Ti Dissolve in 0.1 M NaOAC (pH 5.2), 0.001 M
EDTA, heat in a boiling water bath for 5 
minutes to inactivate any DNases. Store at- 
20°C.
DNase I (Free of RNase) Unfortunately, many commercial preparati ons
of pancreatic DNase I, even those sold as
"RNase-free" are contaminated by amounts of
ribonuclease that are sufficient to cause 
significant degradation of high-molecular- 
weight RNA. Two methods are available to 
remove the contaminating RNase activity.
1. Affinity chromatography on agarose- 
coupled 5’-(4-aminophenyl-phosphoryl uridine 
2 *(3’) phosphate.
2. macaloid suspension method.
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APPENDIX 3. Enzyme buffer 
Buffer
10X T4 DNA ligation buffer 
T4 ENA ligase buffer 
10X T4 Kinase Forward buffer 
10X T4 Kinase Exchange buffer 
10X TdT buffer 
10X Agarose gel dye
Preparation / Composition
Klenow fragment dilution 
buffer
IX Bal31 buffer
5X T4DNA polymerase buffer
10X Nick translation buffer
Nick Translation dNTP mix 
Restriction Endonuclease
250 mM Tris-HCl (pH 7.8), 100 mM MgCl2 , 
10 mM DTT, 4 mM ATP, Store at -20°C.
50 mM Tris-HCl (pH 7.8), 6mM MgCl2, 20 mM 
DTT, 1.0 mM ATP.
500 mM Tris-HCl (pH 8.0), 100 mM MgCl2, 
150 mM DTT, 3.3 uM ATP.
500 mM Imidazole HC1 (pH 6 .8 ), 120 mM
MgCl2, 100 mM DTT, 2 mM ADP, 100 uM ATP.
250 mM Potassium Cacodylate (pH 7.2), 20 
mM CoCl2, 10 mM DTT.
0.25% Bromophenol blue, 0.25% Xylene 
cyanol, 25% Ficoll (type 400) in H20, 
store at room temperature.
10 mM Tris-HCl (pH 8.0), cool the buffer 
before use.
12 mM CaCl2, 12 mM MgCl2, 20 mM Tris-HCl 
(pH 8.0), 1 mM EDTA (pH 8.0), 600 mM
NaCl.
165 mM Tris-HOAC (pH 7.8), 330 mM KOAC, 
50 mM Mg(OAC)2, 2.5 mM DTT, 0.5 mg/ml
BSA.
0.5 M Tris-HCl (pH 8.0), 0.05 M MgCl2,
0.1 M 2-Mercap toethanol, 0.5 mg/ml
nuclease free BSA.
3 mM dNTPs except the radioactive dNTP 
one.
Tris-
Buffers ( IX ): KC1 HC17 • s MgCl2 DTT BSA NaCl
(mM) (mM) (mM) (mM) (ug/ml) (mM)
Buffer A _ 25 1 0 1 1 0 0 50
Buffer B - 25 1 0 1 1 0 0 -
Buffer C - 25 1 0 1 1 0 0 1 0 0
Buffer D 25 25 1 0 1 1 0 0 -
Buffer E - 25 2 1 1 0 0 50
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Note 1: To digest crude prepared DNA, use same restriction 
buffer except use double concentration of MgCl2 .
2: The buffer system is established by International 
Biotechnologies Inc.
3: For double or more digestion, add 1 ul 1 M NaCl to each 
20 ul reaction mixture after each incubation interval.
4: Use 1 unit restriction enzyme for 1 ug linear DNA(e.g., 
lambda phage DNA), 2-3 units restriction enzyme for 1 
ug circular DNA (e.g., pBR322 DNA).
APPENDIX 4. Oligonucleotide sequence
Name Sequence
PFKO (N-probe) 3’ <--GT5CT6CT6GT5GT5CG J 5>
PFIvl 3' <--GTACTTGTCGTGGTACGTCGG----J 5’
PFK1.5 5’-|---ATGATGCTGCAGCT •> 3’
PFK2 3*-<---CT5TT5CT5AA5AC5CC ! 5’
PFK3 3’-<---T5CT5TT5ACCCT6CT J 5’
PFK4 3'-<---AA5TACTT5TT5ACCCT ! 5’
PFK5 3’-<---TT6GT6AA5CT5CT —  ! 5 ’
PFK6 3’-<---TACTTGACCTACCG-----------J 5’
PFK7 5' |---CTGGAGCACATCTCCCG > 3’
PFK1N 5’ !---ATGACCCATGAAGAGCACCA---- > 3’
PFK7C 3’ <---AGACCCCTTCGGTGGCAGATT 1 5’
PFKGAP1 3’ <--- GTCGAGACGTAGGGA  ! 5’
PFKGAP2 5’ !---TGGACCGGGCAAGGCGGC------ > 3’
PFKGAP3 3’ <---GAATGTGGCCCCCGGA---------! 5’
PFK14 3’ <---AA5AA5CA7GT5CT---------- ! 5’
PFK31 3’ <---CT6CC7CA7TT6CT---------- ! 5’
PFK33 3’ <---CG7TACCT5CT6TT---------- ! 5’
PFK51 3* <---TA7AA5CT6CT6GG---------- i 5’
PFK52 3’ <-- CT5AA5TA7AA5TT----------- ! 5>
PFK65 3’ <---GTTGGTCACTGACTC--------- ! 5’
PFIvMC 3’ <-- CC 7 TACTT5CG7CG----------- ! 5’
PFIvl01 3’ <-- CC7GT5TACGT6GT-----------! 5'
PFIvl02 5’ !--A5AT7GC7GC7GGAC----------> 3’
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PFK103 5’ !---GC7GG7GC7GA6GC---------- > 3’
PFK104 3’ <---CG7CT5CG7CG7AT \ 5’
PFK105 5’ 1---GA5AA6TA6AC7AC7G---------> 3’
PFK106 3'-<---CT6TT5AT5TG7TG7CT-------- J 5'
PFK515 5* !---CA5AA5ATGAA5AC-----------> 3’
PFK516 3’ <---GT6IT6TACTT6T G -----------j 5’
Ml3 sequence primer 5’ <---TGACCGGCAGCAAAATG-------- 1 5’
(17 mer)
M13mpl8/20 mer (EcoRI) 5’ \--- GAATTCGTAATCATGGTC  > 3’
Note: 5 represents AG redundency, 6 represents TC redundency, 7 repre­
sents ACGT redundency.




K803 supE+ , supF+ r-Km-K or r-K̂ +K
JM105 thi, rpsL, endA, sbcB15f 
traD36, proAB, lacI<iZAM15]
hspR4, A( lac-proAB), 1 F’,
JM107 endAl, gyrA96, thi, hsdR17, 
A(lac-pro AB), [F*, traD36,
supE44, relAl,A”» 
proAB, lacI<JZAM15]
JM83 ara, lac-proAB), rpsL(=strA), 080, lacZ&Ml5








Plasmid pBR322 4.3 (Bolivar, 1978)
Plasmid pBR325 5.9 (Soberon et al., 1980)
Plasmid pBR328 4.9 (Covarrubias et al., 
1981)
Plasmid pUC9 2.7 (Vieria & Messing, 1982)
Plasmid pUC1 2 2.7 (Vieria & Messing, 1982)
Plasmid pUC18/19 2.7 (Vieria & Messing, 1982)
Bacteriophage M13mp 10/11 7.2 (Messing, 1983)
Bacteriophage M13mp 18/19 7.2 (Yanisch-Perron et 
1985)
al.,
Bacteriophage lambda Charon4A 45.4 (Blattner et al., 1977)
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Plastic bag sealer Audion Electro
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Controlled Environment New Brunswick Scientific
incubator shaker
Rotalling Shaker Warner-Chilcott Lab.
Shaker New Brunswick Scientific
Incubation room Scientific Systems
Photoelectric Colorimeter Klett-summer son
Laboratory Sterilizer Amsco (General purpose)





Squencing Pipet Drummond Scientific
Ultra Low Freezer Revco











Nitrocellulose filter Schleicher & Schuell 8 8x8 8 mm SQUARES
paper 8 8 mm ROUND
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APPENDIX 7. Experimental protocols
A. Preparation of Competent Cells and Transformation
This protocol was adapted from that used by Hanahan (Hanah- 
an, 1983). It has been used for routine cloning works and 
seems reliable and simple. The source of chemicals and the 
preparation of reagents can be easily found in APPENDIX 1.
1. Pick a single JM 107 colony off a streaked M-9 plate and
grow it overnight in 3 ml YT medium at 37°C with agitation.
2. Dilute the overnight inoculum 1:100 into 50 ml YT medium and
grow it at 37°C for 2.5 hours.
@ Start to prepare soft agar 3 ml for each tube and leave it 
at 42°C.
3. Transfer 25 ml of culture into a sterile Oak Ridge centri­
fuge tube and cool on ice for 10 minutes. (Save remaining 25 
ml in Falcon tube for lawn cells).
@ Aliquot 0.2 ml lawn cells in each tube, leave it at room 
temperature.
4. Centrifuge cells at 4000 rpm in SS-34 rotor for 5 minutes at 
4°C.
5. Resuspend cells in 8 ml cold TFB by gently vortexing, place 
on ice for 1 0 minutes.
6 . Centrifuge again (as in step 4).
7. Resuspend in 2 ml cold TFB.
8 . Add 70 ul DMSO, swirl and leave on ice for 5 minutes.




10. Add another 70 ul of DMSO, leave on ice for 5 minutes.
11. Quickly aliquot 200 ul of these competent cells into each 
prechilled glass test tube (ligated DNA must be added to the 
bottom of each tube before this step), swirl and incubate on 
ice for 30 minutes.
@ Add 10 ul of 100 mM IPTG and 50 ul of 2% X-gal in each 
soft agar tube.
12. Heat-shock at 42°C for 90 seconds without agitation.
13. Place on ice for 90 seconds.
14. Pour soft agar into lawn cells and vortex, then pour this 
mixture into the competent cells and vortex, finally pour 
the whole mixture on YT plate.
15. Leave plates on bench until completely solidified.
16. Invert the plates and incubate at 37°C overnight.
B. Direct Gel Electrophoresis (DIGE)
This protocol was adapted from that used by Messing (Messing,
1983). It has been used to screen M13 clones and tested.
1. Centrifuge the phage stocks for one minute.
2. Remove 15 ul from the supernatants of each tube, place in a new 
tube, and add 1 ul of 2% SDS and 4 ul of 10 X Agarose gel load­
ing buffer, vortex and centrifuge briefly.
3. Electrophorese the samples in a 0.8% agarose gel at 20 volts for
overnight (or 70 volts for five hours). Use M13mp28 as size
marker.
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4. Stain the gel with 1 ug/ml EtBr and photograph it.
C. Complementary Test (C-test)
This protocol was adapted from that used by Messing (Messing, 
1983). It has been used to distinguish the complementary in­
serts in Ml3 clones.
1. Take 20 ul of the supernatant from clone A and B respectively
and mix it well in an Eppendorf tube.
2. Add 1 ul of 2% SDS to lyse the phage.
3. Incubate the mixture at 65°C for 90 minutes to allow hybridiza­
tion to occur.
4. Cool the mixture at room temperature for 10 minutes.
5. Add 8 ul of 10 X Agarose gel loading buffer to tube and load 25
ul of the mixture to a 0 .8% gel and electrophorese at 2 0 volts
overnight (or 70 volts for 5 hours) using M13mpl8 as size
marker.
6 . Stain the gel with ethidium bromide and photograph it.
D. Dot Hybridization
This protocol was modified from that used by Messing (Messing, 
1983) and Maniatis (Maniatis et al., 1982). It was used to 
screen M13 library and seems simple and reliable.
1. Centrifuge the phage stocks for one minute.
2. Spot 1 ul of supernatant on a Nitrocellulose filter (NCF) paper, 
let the NCF air dry.
3. Denature the NCF in denaturing solution for one minute.
4. Neutralize the NCF in neutralization solution for five minutes.
5. Rinse the NCF in 2 X SSPE.
6 . Bake the NCF under vacuum at 80°C for two hours.
7. Wet the NCF in 6 X SSC for five minutes.
8 . Prehybridize the NCF in prehybridization solution at 42°C for 
four hours.
9. Hybridize the NCF in hybridization solution containing 1 x 107 
cpm 3 2P-labelled probe overnight.
10. Wash the NCF twice in 2 X SSC and 0.1% SDS at room temperature 
for 1 0 minutes.
11. Wash the NCF twice in 1 X SCC and 0.1% SDS at 6 8 °C for 1.5 
hours.
12. Ex-pose the NCF under an X-ray film at room temperature or -70“C 
with an intensifier onvemight.
Mini Screen -- Quick Isolation of Small Amounts of RF
This protocol was adapted from that used by Birnboim (Birnboim & 
Doly, 1979). It has been used to isolate small amounts of RF or 
plasmid DMAs.
1. Resuspend phage stocks.
2 Inoculate 3 ml of IT medium with 5 ul of phage stock and incu­
bate at 37°C overnight with shaking.
3. Pour 1.5 ml of the culture into a eppendorf tube, centrifuge for 
one minute.
I l l
4. Drain the supernatant, leaving the pellet as dry as possible.
5. Resuspend the pellet in 100 ul of ice-cold solution I.
6 . Store for five minutes at room temperature.
7. Add 200 ul of ice-cold solution II. Mix the contents by invert 
ing the tube rapidly three times. Do not vortex. Store the 
tube on ice for five minutes.
8 . Add 150 ul of ice-cold solution III. Mix the content by invert­
ing the tube rapidly for five times. Store on ice for five 
minutes.
9. Centrifuge at 4°C for 5 minutes.
10. Transfer the supernatant to a fresh tube.
11. Add 0.5 ml of phenol/chloroform. Vortex and allow to stand at
room temperature for 2 minutes. Vortex again, and centrifuge at
room temperature for 2 minutes. Transfer the supernatant to a
fresh tube. Do not transfer the interface.
12. Add 1 ml of ethanol at room temperature. Vortex and then stand 
at room temperature for 2 minutes.
13. Centrifuge at room temperature for 5 minutes.
14. Remove the supernatant. Stand the tube in an inverted position 
on a paper towel to allow all of the fluid to drain away.
15. Wash the pellet with 1 ml of 70% ethanol and recentrifuge at
room temperature for 5 minutes.
16. Remove the supernatant and dry the pellets briefly by a vacuum 
pump.
17. Dissolve the DMA in 50 ul of TE (pH 8.0).
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F. Large-Scale Preparation of RF
This protocol was adapted from that used by Birnboim (Birnboim k 
Doly, 1979) and Maniatis (Maniatis et al., 1982).
1. Inoculate 15 ml VT broth with a single cloning of JM 107 cells. 
Grow7 overnight at 37“C wTith agitation.
2. Inoculate 500 ml YT culture with 5 ml overnight culture and add 
10 ul of Ml3 phage solution. Grow culture for 16 hours at 37°C 
with agitation (250 rpm).
3. Harvest the bacterial cells by centrifugation at 4000 g.for 10 
minutes (5000 rpm, 5 minutes for GSA rotor in 250 ml bottles) at 
4°C. Discard the supernatant.
4. Wash cell pellet with ice-cold STE.
5. Resuspend the cell pellet from a 500 ml culture in 10 ml of 
solution I containing 5 mg/ml lysozyme. (Add lysozyme right 
before use.)
6 . Add 20 ml of freshly made solution II and mix the contents gent­
ly. Let stand on ice for 10 minutes.
7. Add 15 ml of ice-cold solution III and mix the contents by 
inverting the tube sharply several times. Let stand on ice for 
1 0 minutes.
8 . Transfer to 40 ml centrifuge tube and centrifuge in a SS-34 
Rotor (or its equivalent) at 12,000 rpm for 30 minutes at 4°C. 
The cell DNA and bacterial debris should form a tight pellet on 
the bottom of the tube.
9. Transfer equal quantities of the supernatant into each of two
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clean 40 ml centrifuge tubes.
10. Add 0.6 volumes of isopropanol to each tube. Mix well and let 
stand at room temperature for 15 minutes.
11. Recover the DNA by centrifugation in a SS-34 rotor at 12,500 rpm 
for 30 minutes at room temperature.
12. Discard the supertantant, wash the pellet with 70% ethanol at 
room temperature. Discard as much ethanol as possible, then dry 
the pellet briefly under vacuum.
13. Dissolve the pellets in a total volume of 10 ml of TE (pH 8.0).
14. Measure the volume of the DNA solution. For every ml add 
exactly 1 g of solid CsCl. Mix gently until all of the salt is 
dissolved.
15. Add 1 ml of a solution of ethidium bromide (10 mg/ml in H2O) for 
every 10 mi of CsCl solution. Mix well.
16. Centrifuge at 10,000 rpm for 10 minutes at room temperature to 
remove protein.
17. Measure and adjust the density. The final density of the 
solution should be 1.55 g/ml.
18. Transfer the CsCl solution to a tube suitable for a Ti75 rotor
(or Ti50, or Ti65).
19. Centrifuge at 64,000 rpm for 16 hours at 20°C.
20. Two bands (or 3 bands) of DNA should be visible under UV light.
The upper band consists of linear bacterial DNA and nicked cir
cular DNA; the lower band consists of closed circular RF DNA. 
(The extra band represents the single stranded template DNA).
21. Collect the lower band of DNA into a tube through a needle 
inserted into the side of the tube.
22. Remove the EtBr by using 1-butanol saturated with water (using
clinical centrifuge and the DNA will be lower layer).
23. Dialyze the aqueous phase against several changes of double
distilled water.
24. Measure OD2 6 0 , OD2 s 0 .
Preparation of Template DNA
This protocol was adapted from that used by Sanger (Sanger et 
al., 1980). It has been used to prepare template DNA for sequ­
encing. Normally, the template DNA from 1.5 ml culture is 
enough for 5 sequencing uses.
1. Inoculate two tubes containing 3 mis of IT medium with an 
individual colony from the M-9 plate of JM 107 cells and grow 
with shaking at 37°C for overnight.
2. Dilute enough of the overnight culture by 1:100 ratio with YT 
medium so that 3 mis is available for each sample.
3. Add 5 ul of supernatant of stock phage culture to tubes contain­
ing 3 mis of YT medium.
4. Grow cells with vigorous shaking at 37°C for 5 hours.
5. Transfer 1.5 ml of the culture to eppendorf tube and centrifuge 
for 5 minutes.
6 . Pour the supernatant to a clean eppendorf tube taking care not 
to carry over any cells and add 200 ul of 20% PEG solution.
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7. Vortex the supernatant well and leave at room temperature for 30 
minutes.
8 . Centrifuge for 5 minutes and remove the PEG supernatant.
9. Respin the tube for 30 seconds and remove all residual PEG.
10. Resuspend the phage pellet in 100 ul of TE (pH 8.0)
11. Add an equal volume of buffer saturated phenol, vortex well and 
leave for 5 minutes. Vortex and centrifuge for 2 minutes.
12. Transfer upper aqueous layer to a new tube and add 1/10 volume 
of 3M NaOAC, 2.5 volume of EtOII and precipitate at -70°C for 30 
minutes.
13. Centrifuge for 10 minutes at 4°C and carefully pour off the 
ethanol.
14. Wash the pellet with 70% ethanol, centrifuge again and pour off 
the ethanol carefully.
15. Vaccum dry the pellet and redissolve in 25 ul of TES • 0 and store 
at -2 0 °C.
16. Take 5 ul to run a 0.8% Agarose gel to check the purity and 
concentration using 1 ug single stranded M13mpl8 as a size 
marker (If necessary, take 5 ul from each sample to run comple­
mentary test. Theoretically, purified s.s.DNA give a better 
resolution.)
H. Preparation of Buffer Gradient Polyacrylamide Gel
This protocol was modified from that used by Biggin (Biggin 
et al., 1983) and BRL company (Ml3 cloning and sequencing manu
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al). It has been successfully used to sequence the 17 kbp rabbit 
muscle PFK gene.
A 0.5X / 2.5 X TBE gradient across a 6% acrylamide gel is 
used for running the sequencing reactions. The gradient covers 
the lower third of the gel and is generated in a pipet by limi­
ted mixing of two solutions.
Carefully clean one pair of glass gel plates with detergent. 
Siliconize the inside of the smaller plate by wiping with glass 
wool and allow to dry in an oven at 60°C. Wash away the remain­
ing siliconizing solution with water and dry the plate again, 
(treat only one side of one plate and the siliconized plate is 
good for 5 to 6 uses.)
Right before use, wipe clean with 95% EtOH.
Assemble the glass plates using side and bottom spacers and 
bulldog clamps.
For a 43 cm x 35 cm gel, put 10 ml 2.5 X TBE gel mix and 65 ml
0.5 X TBE gel mix into two separate beakers.
Initiate polymerization by adding first 26 ul (to the 2.5 X) and 
167 ul (to the 0.5 X) of 10% Ammonium Persulfate and then adding 
10 ul (to the 2.5 X) and 65 ul (to the 0.5 X) of TEMED.
Using a pipet aid and a 25 ml pipet first take 12 ml of 0.5 X 
TBE gel mix and then 8 ml of 2.5X TBE gel mix. Form a rough 
gradient by allowing 5 air bubbles to pass through the inter­
face .
Pour the gradient down the inner edge of the gel plates held at
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an angle of approximately 45“. Adding the gel mix slowly and 
maintain an even flow. When the pipet is empty, lower the 
plates to horizontal and quickly take up and add the remaining
0.5 X TBE gel mix using the same pipet to fill the glass plates.
9. Put the comb in place and clamp the top edge of plates with 3 
bulldog clamps and leave the gel at least for 1 hour to polymer­
ize.
10. If the polymerized gel is stored overnight, cover the top of gel 
with Saran Wrap to prevent drying out.
I. Dideoxy Sequencing and Gel Running
This protocol was modified from that used by Biggin (Biggin et 
al., 1983) and Ahlquist (Ahlquist, lab. manual) and Sanger (San­
ger , lab. manual).
1. For each template to be sequenced, Pipetts the following onto 
the walls of a 1 .5 ml eppendorf tube:
d.d.IbO 2.5 ul
2.5 ng/ul Primer 1 ul
T.M. 1.5 ul
template DNA 5 ul
Total Volume 10 ul
2. Centrifuge to mix and place in a 60°C water bath for 30 minutes. 
Cool for 10 minutes at room temperature and centrifuge to coll­
ect liquid.
3. Label uncapped eppendorf tubes with A, C, G, T along with clone
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number. (If more than one clone, arrange all A tubes in one lane 
of microfuge rack, all C tubes in another, etc.)
4. For each of N = A, C, G, and T, mix
dNTP mix. 0.9 ul
ddNTP 0.9 ul
S3 5dATP(11.9uci/ul) 0.2 ul
Total Volume 2 ul
for each clone (if more than one clone, multiply the volume by 
the number of clones).
5. Dispense 2 ul of annealed template to each of A, C, G, T tubes 
and then add 2 ul of A mix to the inside edge of A reaction 
tube, (add C, G, T mix in the same way).
6 . Dilute Klenow fragment of DNA polymerase I to 0.15 units/ul in 
ice-cold 10 mM Tris-Cl (pH 8.0) and add 2 ul onto the walls of 
each tube wTithout delay.
7. Start reactions by centrifuging briefly to mix components at 
room temperature.
8 . After 20 minutes, add 2 ul chase solution and let reaction go 
for another 15 minutes.
9. At 35 minutes, add 4 ul FDE.
10. Heat tubes in a 95°C water bath for 5 minutes and quickly chill 
the tubes in ice.
11. Load appropriate amount of sample using Drummond Sequencing 
Pipet to the prerun gel and run the gel at 45 watts until the 
fast dye reaches the bottom of gel.
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12. Remove the top buffer and bulldog clamps.
13. Tilt the glass plates to drain away the buffer left between
plates.
14. Carefully separate two glass plates using spatula, leave gel 
lying on the larger plate.
15. Fix gel in 10% Methanol/10% Acetic Acid for 15 minutes.
16. Remove the plate with gel from the methanol/acetic acid bath.
17. Cover the gel with two sheets of 3 MM paper and invert the glass 
plate to transfer the gel to the 3 MM paper.
18. Cover the gel with Saran Wrap and dry the gel at 80°C for one 
hour using gel dryer.
19. In the dark, place a sheet of X-ray film on top of the gel and
expose at room temperature for 2 0 hours.
20. Develop the film for 5 minutes and fix the film for another 5 
minutes.
J. Dideoxy Sequencing with Microtiter Plate
This protocol was adapted from that used by Deininger (Deinin- 
ger, lab. manual). This protocol was developed for large-scale 
sequencing works.
1. Label the first codon with clone number and the first row with
A, C, G, and T respectively.




2.5ng/ml Primer 1 ul
T.M 1.5 ul
Template DNA 7 ul
Total Volume > 1 2 ul
3. Cover the wells with a layer of Saran Wrap and centrifuge brief­
ly-
4. Place in an oven at 55°C for 45 minutes.
5. Let stand at room temperature for 10 minutes.
6 . Centrifuge the plate briefly to concentrate any condensation and 
remove the Saran Wrap.
7. Distribute 2 ul of annealed mixture to the rim of each A, C, G, 
and T well.
8 . Add 2 ul of dNTP/ddNTP35SdATP mixture to the rim of each A, C,
G, and T well.
9. Without delay, dilute Klenow to 0.15 units/ul with cold 10 mM 
Tris (pH 8.0) and add 2 ul to the rim of each A, C, G, T well.
10. Centrifuge briefly and let stay in centrifuge at room tempe­
rature for 2 0 minutes.
11. To each well add 0.5 mM dNTPs chase solution and centrifuge 
briefly to mix and leave at room temperature for 15 minutes.
12. Plate can be stored at -20°C (or -70°C) for several days, if gel 
will not be run immediately after this step.
13. Add to each well 2 ul of Formamide dye and centrifuge briefly.
14. Heat denature the reactions by placing the plate in an oven at
80°C for 15 minutes.
15. Cool the plate at -20°C for 2 minutes.
16. Samples are ready to load the gel at this step.
Restriction Endonuclease Partial Digestion
This protocol was adapted from that used by Smith (Smith & 
Birnstiel, 1976). It has been tested and seems reliable.
1. Use wild type lambda DNA to titrate different restriction 
endonuclease and find out the best condition for partial diges­
tion.
2. Radioactively label DNA fragments at 3' or 5’ end.
3. Use Hindlll and EcoRI digest of wild type Lambda DNA as a size 
marker with 5’end labelling.
4. Use buffer A for PstI, PvuII, and Hindlll; use buffer B for SstI 
and Xmal; use buffer C for BamHI, Sail, Xbal, and SphI; use bu­
ffer D for Smal, buffer E for HincII.
5. Incubate 15 uls of solution (1 unit of restriction enzyme/1 ug 
of DNA) at 37°C for short time; for PstI: 8 minutes, for PvuII 
and BamHI: 40 minutes, and for all the other restriction enzy­
mes : 30 minutes.
6 . Digest 104 - 105 cpm (Crenkov counts) of each restriction
endonuclease.
7. Terminate reaction by heating at 70°C for 5 minutes.
8 . Add 2 uls of 10 X loading dye.
9. Load sample in a 1.2% Agarose gel (104 cpm for each bound will
be seen clearly after overnight exposure at room temperature).
10. Run gel electrophoresis in 1 X TBE buffer at 70 volts for 4 - 5  
hours.
11. Dry the gel on a gel drier at 60°C for 30 minutes.
Nick Translation
This protocol was adapted from that used by Rigby (Rigby et al., 
1977) and BRL company (product profile).
1. Pipette the following into a 1.5 ml microcentrifuge tube:
5 uls of solution A (0.2 mM each of the dNTP’s except dCTP)
1 ug of DNA
5 uls of radioactive nucleotide ( alpha3 2 P"dCTP ) 
make up volume to 45 uls using ddlhO and centrifuge the mixture 
briefly.
2. Spot 1 ul of the solution on TLC plate for original control.
3. Add 5 uls of solution C (0.4 units/ul DNA polymerase I, 40 pg/ul 
Dnase I, 50 mM Tris-Cl (pH 7.5), 5mM Mg-acetate,l mM 2-mercapto- 
ethanol, 0.1 mM FWSF, and 50%{V/V) glycerol, 100 ug/ml nuclease- 
free BSA).
4. Mix gently but thoroughly, centrifuge the mixture briefly.
5. Incubate the mixture at 15°C for 60 minutes.
6 . Spot 1 ul of the mixture on TLC plate and leave the reaction 
tube at -20°C.
7. Run TLC in 0.75 M NaHzPO4 (pH 3.5) for 30 minutes.
8 . Dry TLC plate and expose under an X-ray film.
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9. If reaction is O.K., add 25uls of 7.5M NH4OAC to the tube.
10. Add 150 uls of ethanol.
11. Leave the tube at -70°C for 30 minutes.
12. Centrifuge for 15 minutes.
13. Redissolve in 100 uls of double distilled water.
14. Spot 1 ul of it on a piece of 3 MM paper and count the activity
using liquid scentillation counter.
15. Normally 107 - 10s cpm per ug DNA cam be obtained.
M. 5’ End Kinase-Forward Reaction
This protocol was adapted from that used by Chaconas (Chaconas & 
van de Sande, 1980).
1. Pipette the following into a 1.5 ml microcentrifuge tube:
2.5 uls of 10 X Forward-Reaction buffer: (500 mM Tris-HCl (pH
8.0), 100 mM MgClg, 150 mM DTT, 3.3 uM ATP)
10 uci of [gamma-3 2P]-ATP
5 p mole ends dephosphorylated. DNA fragments.
make up volume to 25 uls with double distilled water.
2. Spot 0.5 ul of solution on TLC plate.
3. Add 5 units of T4 Kinase.
4. Incubate the mixture at 37°C for 30 minutes.
5. Spot 0.5 ul of the mixture on TLC plate and leave the reaction 
tube at -20°C.
6 . Run TLC in 0.75 M NaHzPCh (pH 3.5) for 30 minutes.
7. Dry TLC plate and expose under an X-ray film.
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8 . If reaction is O.K., add 25 uls of d.d.HaO, 25uls of 7.5 M 
NH4OAC and 150 uls of Ethanol.
9. Mix the mixture well and leave it at -70°C for 30 minutes.
10. Centrifuge for 15 minutes and resuspend it in 100 uls of d.d.
H20.
11. Spot 1 ul of the mixture on a piece of 3 MM paper and count the 
activity using liquid scintillation counter.
12. Normally, 105 - 106 cpm per p mole end can be obatined.
Note: for a 15 mer Oligonucleotide; 5 ng = 1 p mole 5’end
N. 5' End Kinase-Exchange Reaction
This protocol was adapted from that used by Chaconas (Chaconas k 
van de Sande, 1980).
1. Pipette the following into a 1.5 ml microcentrifuge:
2.5 uls of 10 X Exchange Reaction buffer: (500 mM Imidazole
HC1, PH up to 6.8 with HC1, 120 mM MgCl2, 100 mM
DTT, 2 mM ADP, 100 uM ATP)
50 uci of [gamma-32P]-ATP 
5 p mole ends of DNA fragments 
make up volume to 25 uls with d.d.H20
2. Spot 0.5 ul of the solution on TLC plate.
3. Add 5 units of T4 Kinase.
4. Incubate the solution at 37°C for 30 minutes.
5. Spot 0.5 ul of the solution on TLC plate and leave the reaction
tube at -20°C.
6. Run TLC in 0.75 M NaJfcPOij3-5 for 30 minutes.
7. Dry TLC plate and expose under an X-ray film.
8. If reaction is O.K., add 25 uls of d.d.HzO, 25uls of 7.5 M 
NILOAC and 150 uls of Ethanol.
9. Mix the mixture well and leave it at -70°C for 30 minutes.
10. Centrifuge for 15 minutes and resuspend it in 100 uls of double 
distilled water.
11. Spot 1 ul of the mixture on a piece of 3 MM papier and count the 
activity using liquid scintillation counter.
12. Normally, 104 - 105 cpm per p mol end cam be obtained.
3’ End Labelling Reaction
This protocol was adapted from that used by IBI company (commer­
cial catalog).
1. Pipette the following into a 1.5 ml microcentrifuge tube:
5 uls of 10 X TdT buffer: (250 mM Potassium Csicodylate (pH
7.2), 20 mM C0 CI2 , 10 mM DTT)
5 uci of Ialpha-32P] dATP 
2 p mole ends of DNA fragments
maike up volume to 50 uls with d.d.lLO.
2. Spot 1 ul of the solution on TLC plate.
3. Add 15 units of TdT (Terminal transferase).
4. Incubate the mixture at 37°C for 30 minutes.
5. Spot 0.5 ul of the mixture on TLC plate and leave the reaction
tu b e  a t  - 2 0 °C.
6 . Run TLC in 0.75 M NaHaPCh (pH 3.5) for 30 minutes.
7. Dry TLC plate and expose under an X-ray film.
8 . If reaction is O.K., add 25 uls of d.d.ILO, 25uls of 7.5 M 
NH4OAC and 150 uls of Ethanol.
9. Mix well said leave the mixture at -70°C for 30 minutes.
10. Centrifuge for 15 minutes and resuspend in 100 ul double distil­
led water.
11. Spot 1 ul of the mixture on a piece of 3 MM paper and count the 
activity using liquid scintillation counter.
12. Normally, 105 - 106 cpm per p mole end csui be obatined.
Purification of Oligonucleotide
a. Manual De-protect Procedure of Oligonucleotide
1. Rinse the vial with 10-12 ml Acetonitrile (HPLC grade) using 
a 10 ml syringe.
2. Dry with Argon for 2 minutes.
3. Add 0.2-0.3 ml of Thiophenol. Allow to stand 45 minutes sind
remove the thiophenol.
4. Rinse with 10-12 ml Methanol (HPLC grside).
5. Rinse with 10-12 ml Acetonitrile.
6. Dry with Argon for 2 minutes.
7. Add 1 ml of Ammonium Hydroxide using a 1 ml syringe. Allow 
to stsind 6 hours to overnight at room temperature.
8. Transfer Ammonium Hydroxide to a 1 dram vial.
9. Add the second 1 ml of Ammonium Hydroxide to the column.
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Allow to stand 10 minutes to 1 hour at room temperature.
10. Add the second ml of Ammonium Hydroxide to the 1 dram vial.
11. Incubate at 55°C for 6 hours to overnight. (Note: Oligonuc­
leotides stored in Ammonium hydroxide are stable at 4°C for 
months. Oligonucleotides that have been evaporated out of 
AmOH and resuspended in water or buffer are stable at -20°C 
for 1 year.
12. Evaporate to dryness using plan-shape flask and rotary 
evaporator.
13. Add 2 mis of 25 mM TEAB (pH 7.6) (Triethylammonium bicarbo­
nate) to redissolve at this point and check the pH which 
should be above 6.
b. Desalting and Isolation of Oligonucleotide
1. Pretreat Sep-pak (a small loosely packed u-Cis reverse phase 
cartridge) as following:
. Flush the cartridge with 10 mis of HPLC grade Acetonini 
trile.
. Flush the cartridge with 10 mis of 30% Acetonitrile/25 mM 
TEAB.
. Flush the cartridge with 10 mis of 25 mM TEAB.
2. Flush onto cartridge the oligonucleotide in 25 mM TEAB, 
maximum capacity ca. 100 Az6o O.D. units.
3. Wash with 25 mM TEAB (5 mis for each time) until A2 6 0 << 0.1
O.D..
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4. Wash with 10% CH3CN/25 mM TEAB (ca. 5 mi).
5. Wash with 30% CHaCN/25 mWTEAB (ca. 5 ml).
6. Evaporate collection from step 5 to dryness.
7. Add 0.5 ml of 80% Acetic Acid to remove the DMTr group for 
25 minutes (orange appear).
8. Evaporate to dryness and azeotroped twice with water. (This 
process separates the failed sequences from the DMTr con­
taining sequences.)
9. Dissolve in 0.5 ml of water and transfer to a 1.5 ml micro­
centrifuge tube and then lyphilized to dryness.
10. Wash pear-shape flask with 80 uls of formamide and transfer 
to microcentrifuge tube.
11. Add 10 uls of loading dye and 10 uls of NaOII.





10X TBE 15 ml
add H2O to 150 ml
10% APS 700 ul
TEMED 25 ul
13. Run gel in IX TBE, 750-1000 volts until the fast moving dye 
reach the bottom of gel.
14. Cover the gel with Saran Wrap and cut above and below the
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tracking dyes and then remove the Saran Wrap.
15. Transfer gel onto a plastic wrap covered fluorescent TLC 
plate (20 x 20 cm). The band(s) can be visualized by illu­
mination with short wave U.V. light.
16. Photograph with 2 short wave U.V. lights on the top of gel
by the condition 1/4.5 x B x 14 seconds or 1/4.5 x 1 x 3
seconds.
17. Excise the slowest moving, most intense band and transfer to 
a 15 ml Corning plastic tube.
18. Crush to a fine powder and add 6 mis of 1 M TEAB.
19. Incubate with gentle, thorough agitation at 37 °C overnight.
20. Recover supernatant by centrifugation or filtration through 
a sinterglass filter. (Pretreat filter using conc.HCl, wash 
with double dllistilled water, then rinse with 1 M TEAB, and 
then wash several times with double distilled ILO).
21. Desalt via another Sep-pak and repeat step 1 to 5.
22. Evaporate to dryness and azeotroped once with water.
23. Redissolve in 0.5 ml of water and dilute 5 uls of the solu­
tion to 1 ml to read OD2 6 0 or scan from OD3 2 0 to OD2 2 0 .
Note: Crude oligonucleotide without further purification
via polyacrylamide is good for probe and sequencing primer. 
However, further purified one will give better and more 
clear result and pattern.
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Q. Hybridization using Oligonucleotide Probe
1. Rewet NCF in 6 X SSC.
2. Prehybridize in 10 X Denhardt's, 6 X SSC, 0.2% SDS, and 50 ug/ml 
yeast tRNA at 55°C for 3 hours.
3. Hybridize in 10 X Denhardt's, and 6  X SSC at ( T d - 4) overnight. 
{Add probe right before use.)
4. Wash in 6 X SSC at room temperature first for 10 minutes. If 
background is still high, then temperature can be increased 
gradually until the maximum temperature ( Td +2 ).
Note: add 2°C for each AT pair, 4°C for each GC pair, and 2°C 
for each redundancy, then the summary is the dissolation temp 
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